Ophthalmology – Guillain–Barré Syndrome and Fisher Syndrome Variant

Basics

Description

Guillain–Barré syndrome (GBS) is an acute immune-mediated inflammatory disorder predominantly affecting the peripheral nerves and nerve roots. The classic demyelinating form is also called acute inflammatory demyelinating polyneuropathy (AIDP).

The clinical spectrum includes:

• Classic Guillain–Barré syndrome
• Fisher syndrome (FS), also called Miller Fisher syndrome
• Bickerstaff brainstem encephalitis (BBE)
• Other less common GBS variants

The disorder is frequently postinfectious, resulting from an autoimmune response triggered by a preceding infection.

⚠️ Clinical Alert: Ascending paralysis can progress rapidly and involve the respiratory muscles, resulting in respiratory failure. Respiratory and autonomic monitoring is essential.

Epidemiology

The incidence of GBS is approximately 0.6–4 cases per 100,000 population.

Fisher syndrome represents approximately 1–7% of GBS-spectrum cases in Western countries, but may account for up to 25% in Japan.

Men are affected more frequently than women.

GBS can occur at any age but is most frequent from the third through seventh decades. Fisher syndrome has been reported to show peaks in approximately the fourth and sixth decades.

Risk Factors

Important precipitating factors include preceding infection, surgery, and occasionally immunization.

Antecedent Infections

Approximately two-thirds of patients report an infection before neurologic symptoms begin.

Important organisms include:

• Campylobacter jejuni
• Haemophilus influenzae
• Cytomegalovirus
• Epstein–Barr virus
• Other viral respiratory or gastrointestinal infections

Pathophysiology

GBS is primarily an immune-mediated attack on peripheral nerves.

An infectious or other antigenic exposure triggers antibodies and cellular immune responses that cross-react with components of peripheral nerves through molecular mimicry.

This can produce:

• Peripheral nerve demyelination
• Perivascular inflammatory infiltration
• Conduction block
• Variable secondary axonal injury
• Wallerian degeneration in severe disease

Certain GBS variants are more strongly associated with antibodies directed against specific neuronal gangliosides.

Anti-GQ1b Antibodies

Anti-GQ1b antibodies are particularly important in Fisher syndrome.

They are present in the great majority of patients with typical Fisher syndrome and correlate strongly with ophthalmoplegia and ataxia.

Etiology

The underlying mechanism is an autoimmune response following exposure to an antigen, usually from an antecedent infection.

The resulting immune response mistakenly targets peripheral nerve components.

Diagnosis

History

Classic GBS usually begins with acute or subacute weakness.

Weakness typically starts in the distal lower extremities and progresses proximally over hours to days, producing the characteristic ascending paralysis.

Sensory symptoms such as numbness, paresthesias, or neuropathic discomfort may occur but are usually less prominent than motor weakness.

As the disease progresses, cranial nerves may become involved, producing:

• Facial weakness
• Ptosis
• Diplopia
• Dysphagia
• Dysarthria

Bulbar and respiratory involvement can become life-threatening.

Fisher Syndrome Presentation

Fisher syndrome commonly presents differently from classic ascending GBS.

The characteristic initial complaints are:

• Diplopia
• Gait instability or ataxia

Physical Examination

Classic GBS

The characteristic neurologic findings include:

• Symmetric, usually ascending weakness
• Reduced or absent deep tendon reflexes
• Cranial nerve involvement
• Facial weakness
• Bulbar weakness
• Possible respiratory muscle weakness

Severe bulbar or respiratory weakness can result in apnea and respiratory failure.

Fisher Syndrome – Classic Triad

The classic Fisher syndrome triad consists of:

1. Ophthalmoplegia

Ptosis and ophthalmoparesis are prominent and may progress to essentially complete bilateral ophthalmoplegia.

2. Ataxia

Patients develop significant gait and limb ataxia.

3. Areflexia

Deep tendon reflexes are reduced or absent.

Ophthalmoplegia + Ataxia + Areflexia = Fisher syndrome

Ophthalmic Manifestations

Ptosis and ophthalmoparesis may occur throughout the GBS spectrum but are particularly characteristic of Fisher syndrome.

The ophthalmoplegia can be complex and may demonstrate both peripheral and central patterns.

Findings can include:

• Third cranial nerve paresis
• Fourth cranial nerve paresis
• Sixth cranial nerve paresis
• Symmetric ophthalmoplegia that does not correspond to an individual cranial nerve
• Internuclear ophthalmoplegia
• Vertical gaze abnormalities
• Nystagmus
• Supranuclear gaze abnormalities
• Ptosis

GBS, particularly Fisher syndrome, is an important cause of complete bilateral ophthalmoplegia.

Pupillary Abnormalities

Pupillary involvement can occur.

Some patients develop mydriasis with a poorly reactive pupil.

Light-near dissociation may also occur, in which the pupillary response to light is impaired while constriction during near effort is relatively preserved.

Bickerstaff Brainstem Encephalitis

Bickerstaff brainstem encephalitis overlaps clinically and immunologically with Fisher syndrome.

Characteristic features include:

• Ophthalmoplegia
• Ataxia
• Impaired consciousness
• Hyperreflexia

The presence of altered consciousness and pyramidal tract features helps distinguish BBE from typical Fisher syndrome.

Diagnostic Tests and Interpretation

Lumbar Puncture

The classic cerebrospinal fluid finding is albuminocytologic dissociation:

Elevated CSF protein with few or no white blood cells.

Importantly, CSF protein may remain normal during the first several days of illness. Therefore, a normal early lumbar puncture does not exclude GBS.

Electrodiagnostic Studies

Nerve conduction studies and electromyography may demonstrate a peripheral neuropathy with demyelinating features.

Findings may include:

• Slowed conduction velocity
• Prolonged distal motor latency
• Conduction block
• Prolonged or absent F waves

Some GBS variants predominantly produce axonal abnormalities rather than demyelination.

Anti-GQ1b Antibody

Serum anti-GQ1b IgG antibody is strongly associated with Fisher syndrome and is detected in more than 85% of typical cases.

It is particularly associated with:

• Ophthalmoplegia
• Ataxia

Anti-GQ1b antibodies can also occur in related GBS-spectrum disorders, including Bickerstaff brainstem encephalitis.

Imaging

GBS and Fisher syndrome are primarily clinical diagnoses supported by CSF and electrophysiologic findings.

MRI is principally useful for excluding alternative diagnoses.

Important alternatives include:

• Brainstem infarction
• Brainstem hemorrhage
• Brainstem encephalitis
• Demyelinating disease
• Structural brainstem lesions
• Wernicke encephalopathy

Brain MRI is frequently normal in GBS and Fisher syndrome.

Occasionally, MRI may demonstrate enhancement of cranial nerves or nerve roots.

Pathological Findings

Typical pathology demonstrates:

• Perivenular inflammatory infiltrates
• Segmental demyelination of peripheral nerves
• Variable axonal degeneration

Differential Diagnosis

Important differential diagnoses include:

• Myasthenia gravis
• Brainstem infarction
• Brainstem hemorrhage
• Brainstem encephalitis
• Brainstem tumor or other mass lesion
• Multiple sclerosis or another demyelinating disorder
• Wernicke encephalopathy
• Botulism
• Cavernous sinus disease

In a patient presenting with acute bilateral ophthalmoplegia, ataxia, and areflexia, Fisher syndrome should be strongly considered.

Treatment

Guillain–Barré Syndrome

Two established disease-modifying treatments are used for significant GBS:

Intravenous Immunoglobulin (IVIG)

IVIG is a standard first-line therapy.

Plasma Exchange

Plasmapheresis/plasma exchange is also an effective first-line treatment.

Both treatments can accelerate recovery in appropriately selected patients.

Routine corticosteroid monotherapy is not an effective treatment for classic GBS.

Fisher Syndrome

Fisher syndrome generally has an excellent spontaneous recovery rate.

Because the disease is uncommon and frequently self-limited, evidence supporting specific immunotherapy is less robust than for classic GBS.

Patients with severe disease, respiratory or bulbar involvement, substantial overlap with classic GBS, or Bickerstaff-spectrum disease require particularly close neurologic assessment.

General Management

GBS management extends well beyond immunotherapy.

Important supportive measures include:

• Respiratory monitoring
• Cardiac monitoring
• Monitoring for autonomic instability
• Thrombosis prevention when appropriate
• Physical and occupational rehabilitation
• Nutritional and swallowing support when required
• Prevention of pressure injuries and other complications of immobility

Management of Diplopia

Acute diplopia can be managed symptomatically with:

• Monocular occlusion
• Temporary prisms when appropriate

Persistent ocular misalignment should generally be observed initially because substantial spontaneous recovery may occur.

Corneal Protection

Facial weakness and incomplete eyelid closure can cause exposure keratopathy.

Patients may require:

• Frequent ocular lubrication
• Lubricating ointment
• Eyelid taping or other protective measures when necessary

The cornea should be monitored closely when facial paresis is severe.

Surgery

Surgery is rarely required during the acute disease.

If recovery eventually plateaus with persistent disabling strabismus, ophthalmoplegia, or ptosis, appropriately selected patients may undergo:

• Strabismus surgery
• Eyelid surgery

Surgery should generally be deferred until the neurologic and ocular alignment abnormalities have become stable.

Inpatient Considerations

Admission

Most patients with classic GBS require hospitalization.

Relatively mild and stable Fisher syndrome may occasionally be managed without admission, but careful neurologic assessment is required because overlap with more generalized GBS can occur.

⚠️ Emergency concern: Progressive weakness, bulbar dysfunction, declining respiratory function, severe autonomic instability, or cardiac arrhythmia requires intensive monitoring and potentially ICU management.

Respiratory Monitoring

Respiratory status should be assessed repeatedly because deterioration may occur rapidly.

Progressive respiratory failure requires early airway management and mechanical ventilation rather than waiting for overt respiratory collapse.

Autonomic Dysfunction

GBS can produce substantial autonomic instability, including:

• Bradycardia
• Tachycardia
• Cardiac arrhythmias
• Blood pressure fluctuations
• Other dysautonomic manifestations

Continuous cardiac monitoring may therefore be necessary in significant disease.

Rehabilitation

Physical and occupational therapy are important components of recovery.

Rehabilitation helps maintain joint mobility, prevent complications of immobility, and maximize recovery of strength and function.

Follow-Up

Patients should receive continued neurologic follow-up until recovery is complete or their neurologic deficits have clearly plateaued.

Patients with ophthalmoplegia require ophthalmologic or neuro-ophthalmologic follow-up when diplopia, ptosis, pupillary abnormalities, or exposure keratopathy persists.

Prognosis

Fisher Syndrome

The prognosis is generally excellent.

Recovery often begins within approximately 2 weeks, and substantial recovery commonly occurs within 3 months, although the exact course varies.

Guillain–Barré Syndrome

Most patients experience substantial neurologic recovery, although recovery may require weeks to months.

A subset is left with persistent weakness, sensory symptoms, fatigue, or other neurologic deficits.

Some patients experience recurrent episodes or evolve into a chronic immune-mediated neuropathy such as chronic inflammatory demyelinating polyneuropathy (CIDP).

Key Ophthalmology Points

The most important ophthalmic association is Fisher syndrome, characterized by the triad of ophthalmoplegia, ataxia, and areflexia.

Acute bilateral or complete ophthalmoplegia—particularly when accompanied by gait ataxia and absent reflexes—should prompt consideration of Fisher syndrome and testing for anti-GQ1b antibodies.

Despite the dramatic ophthalmoplegia, the ocular motor prognosis in Fisher syndrome is generally very good.

Ophthalmology – Granulomatous Uveitis

Basics

Description

Granulomatous uveitis is a nonspecific term describing intraocular inflammation with granulomatous features. It may present with a painful red eye, photophobia, floaters, and decreased vision, although the symptoms vary depending on the site and severity of inflammation.

A classic finding is the presence of large, greasy keratic precipitates, often described as mutton-fat keratic precipitates, on the corneal endothelium.

The inflammation may involve predominantly the anterior segment as anterior uveitis or iritis, the vitreous as intermediate uveitis, the retina and choroid as posterior uveitis, or the entire uveal tract as panuveitis.

Granulomatous uveitis is more often associated with an underlying systemic disease, infectious process, or specific ocular syndrome than nongranulomatous uveitis. It may be unilateral or bilateral, acute or chronic, and can occur at any age.

Risk Factors

Risk factors depend on the underlying cause.

Geographic exposure is important, particularly residence in or travel to areas endemic for infections such as tuberculosis, Lyme disease, or coccidioidomycosis.

Animal exposure may also be relevant. For example, certain exposure histories may increase suspicion for toxoplasmosis.

Ethnicity can provide a clue to systemic associations. Sarcoidosis, for example, has varying prevalence among different populations.

A history of penetrating ocular trauma or surgery involving the fellow eye may suggest sympathetic ophthalmia.

Disruption of the lens capsule following trauma or surgery may predispose to lens-associated uveitis.

Genetics

Granulomatous uveitis itself does not have a single genetic pattern.

Some associated diseases have genetic markers. For example, Vogt–Koyanagi–Harada disease has been associated with certain HLA-DR alleles.

Pathophysiology

The exact mechanism varies with the underlying condition.

Granulomatous inflammation may result from an autoimmune response, persistent immune activation against ocular antigens, or the host response to an infectious organism.

The inflammatory reaction typically involves macrophages, epithelioid cells, lymphocytes, and multinucleated giant cells.

Etiology

A substantial proportion of cases remain idiopathic despite appropriate evaluation.

Possible infectious causes include syphilis, tuberculosis, herpes simplex virus, varicella-zoster virus, cytomegalovirus, toxoplasmosis, Lyme disease, leprosy, coccidioidomycosis, and brucellosis.

Important noninfectious causes include sarcoidosis, Vogt–Koyanagi–Harada disease, sympathetic ophthalmia, granulomatosis with polyangiitis, and lens-associated uveitis.

Because treatment differs considerably between infectious and noninfectious causes, identifying the underlying etiology is essential whenever possible.

Commonly Associated Conditions

Granulomatous uveitis may be associated with sarcoidosis, syphilis, HSV, VZV, CMV, tuberculosis, toxoplasmosis, Lyme disease, leprosy, Vogt–Koyanagi–Harada disease, sympathetic ophthalmia, granulomatosis with polyangiitis, coccidioidomycosis, brucellosis, and lens-associated inflammation.

Diagnosis

History

A detailed medical and ocular history should be obtained.

The clinician should ask about prior ocular surgery, trauma, infections, systemic inflammatory disease, and medications.

A complete review of systems should include questions about joint pain, skin rashes, shortness of breath, swollen lymph nodes, headaches, hearing changes, hair loss, skin depigmentation, neurologic symptoms, ocular trauma, insect bites, sexually transmitted infections, tuberculosis exposure, animal exposure, and recent travel.

These findings can help direct the diagnostic workup.

Physical Examination

Visual Acuity

Vision may remain normal in mild disease or may be reduced when inflammation is severe or involves the macula, optic nerve, lens, vitreous, retina, or choroid.

Intraocular Pressure

Intraocular pressure is often reduced during active anterior inflammation because ciliary body dysfunction decreases aqueous production.

However, elevated intraocular pressure may occur in viral uveitis, chronic inflammatory disease, secondary angle damage, or as a response to corticosteroid therapy.

External Findings

External examination may occasionally provide clues to systemic disease.

For example, lacrimal gland enlargement, parotid enlargement, or facial nerve palsy may suggest sarcoidosis.

Conjunctival injection may be present, often with a ciliary flush around the limbus.

In Vogt–Koyanagi–Harada disease, perilimbal depigmentation known as Sugiura sign may develop.

Corneal Findings

Keratic precipitates are deposits of inflammatory cells on the posterior corneal surface.

In granulomatous disease, they are typically large, greasy, and mutton-fat in appearance and are often concentrated inferiorly.

Anterior Chamber Findings

Anterior chamber cells and flare are common.

Cells represent inflammatory cells floating in the aqueous humor.

Using the SUN grading system, anterior chamber cells are graded as follows: 0 for fewer than 1 cell, 0.5+ for 1–5 cells, 1+ for 6–15 cells, 2+ for 16–25 cells, 3+ for 26–50 cells, and 4+ for more than 50 cells in a standardized slit-lamp field.

Flare represents increased protein in the aqueous due to breakdown of the blood-aqueous barrier.

Flare is graded as 0 for none, 1+ for faint, 2+ for moderate with clear iris and lens details, 3+ for marked with hazy iris and lens details, and 4+ for intense flare with fibrin or a markedly turbid aqueous.

Iris Findings

Granulomatous uveitis may produce posterior synechiae, where the iris adheres to the anterior lens capsule.

Peripheral anterior synechiae may also occur.

Inflammatory iris nodules may develop at the pupillary margin, on the iris surface, or within the anterior chamber angle.

Lens Findings

Inflammatory deposits may be visible on the anterior lens capsule.

Patients with recurrent or chronic inflammation may develop posterior subcapsular cataracts, either from the inflammation itself or from prolonged corticosteroid therapy.

Vitreous Findings

Inflammatory cells in the vitreous indicate posterior involvement.

Aggregates of inflammatory cells may form snowballs, particularly in intermediate uveitis.

Posterior Segment Findings

Posterior inflammation may produce optic disc edema, retinal vascular sheathing, retinal vasculitis, focal retinal lesions, choroidal lesions, cystoid macular edema, choroidal granulomas, or exudative retinal detachment.

Diagnostic Tests and Interpretation

Laboratory Evaluation

Laboratory investigation should be directed by the history, review of systems, examination findings, and epidemiologic exposure.

Granulomatous uveitis generally warrants an etiologic evaluation even at the first presentation because of its stronger association with systemic and infectious disease.

A basic evaluation may include a complete blood count and syphilis testing.

Syphilis testing is particularly important because syphilitic uveitis can mimic almost any form of ocular inflammation.

Tuberculosis Testing

When tuberculosis is suspected, testing may include a tuberculin skin test or interferon-gamma release assay, together with appropriate chest imaging.

Sarcoidosis Testing

When sarcoidosis is suspected, chest imaging is important.

Serum ACE and lysozyme may provide supportive evidence but are not sufficiently specific to establish the diagnosis by themselves.

Lyme Disease

Lyme serology should be considered when there is an appropriate exposure history and compatible clinical findings.

Toxoplasmosis

Toxoplasma IgG and IgM testing may be supportive in selected cases, although ocular toxoplasmosis is often diagnosed primarily from the retinal appearance.

Granulomatosis With Polyangiitis

ANCA testing may be useful when granulomatosis with polyangiitis is suspected.

PCR Testing

Aqueous or vitreous PCR can be helpful when an infectious etiology is suspected.

PCR may be performed for HSV-1, HSV-2, VZV, CMV, and Toxoplasma, depending on the clinical pattern.

Imaging

B-Scan Ultrasonography

If media opacity prevents visualization of the posterior segment, B-scan ultrasound may identify vitritis, exudative retinal detachment, subretinal lesions, choroidal thickening, or optic nerve abnormalities.

Fluorescein Angiography

Fluorescein angiography can demonstrate retinal vasculitis, vascular leakage, papillitis, macular edema, and inflammatory retinal abnormalities.

Indocyanine Green Angiography

Indocyanine green angiography provides improved visualization of choroidal inflammatory abnormalities and may be especially useful in diseases such as VKH.

Chest Imaging

Chest radiography may identify hilar or mediastinal adenopathy associated with sarcoidosis or tuberculosis.

If chest radiography is nondiagnostic but suspicion for sarcoidosis remains high, chest CT may be considered.

Biopsy

Biopsy of an accessible conjunctival nodule, lacrimal gland lesion, lymph node, skin lesion, or other involved tissue can help establish diagnoses such as sarcoidosis.

Histopathology classically demonstrates epithelioid histiocytes and multinucleated giant cells within granulomas.

Differential Diagnosis

Important differential diagnoses include endophthalmitis, intraocular lymphoma, chronic retinal detachment, and lens-induced inflammatory disease.

Masquerade syndromes should be considered when the inflammation behaves atypically or does not respond as expected to therapy.

Treatment

Treatment depends critically on whether the uveitis is infectious or noninfectious.

First-Line Treatment

For noninfectious anterior granulomatous uveitis, topical corticosteroids, such as prednisolone acetate, are usually the main initial therapy.

Treatment is often started relatively aggressively and then tapered slowly according to the clinical response.

Cycloplegic agents, such as cyclopentolate, homatropine, or atropine, may be used to relieve pain and photophobia and to prevent or break posterior synechiae.

Treatment of an Identified Cause

When an infectious cause is identified, treatment should specifically target the underlying pathogen.

For example, tuberculosis-associated uveitis requires appropriate antituberculous therapy, syphilitic uveitis requires systemic antibiotic treatment, and herpetic disease requires appropriate antiviral therapy.

Corticosteroids in infectious uveitis should generally be used only in combination with appropriate antimicrobial treatment.

Second-Line Treatment

If important infectious causes have been excluded and inflammation remains inadequately controlled with topical therapy, periocular or systemic corticosteroids may be necessary.

Long-term oral corticosteroid therapy requires monitoring for systemic complications such as hypertension, diabetes, osteoporosis, infection, mood changes, and gastrointestinal effects.

Calcium and vitamin D supplementation and other bone-protective measures may be appropriate when prolonged systemic treatment is anticipated.

Immunomodulatory Therapy

Patients with chronic, recurrent, steroid-dependent, or steroid-resistant noninfectious uveitis may require immunomodulatory or immunosuppressive therapy.

This may include antimetabolites, calcineurin inhibitors, biologic therapies, or other steroid-sparing agents.

Such treatment is usually coordinated with a uveitis specialist and often a rheumatologist.

Intravitreal Steroid Therapy

Intravitreal corticosteroids may be used in selected severe noninfectious cases, particularly when posterior inflammation or macular edema is prominent.

Potential complications include cataract formation and ocular hypertension or glaucoma.

Infectious etiologies should be excluded before intraocular corticosteroids are administered.

Management of Increased Intraocular Pressure

Secondary ocular hypertension or glaucoma should be treated with appropriate pressure-lowering medications.

Persistent elevation or progressive glaucomatous damage may require referral to a glaucoma specialist.

Referral

Patients receiving long-term systemic corticosteroids should be followed by a primary care physician or appropriate medical specialist for monitoring of blood pressure, blood glucose, bone health, and other systemic adverse effects.

Patients who require immunomodulatory therapy may need rheumatology involvement.

If an underlying systemic disease is identified, referral should be directed appropriately, such as pulmonology for sarcoidosis or infectious disease for tuberculosis.

Cystoid macular edema may require a vitreoretinal specialist.

Persistent, recurrent, or diagnostically uncertain inflammation should be referred to a uveitis specialist.

Surgery and Other Procedures

Chronic uveitis and corticosteroid treatment may lead to visually significant cataract requiring cataract extraction and intraocular lens implantation.

Glaucoma that cannot be controlled medically may require trabeculectomy, glaucoma drainage device implantation, or another pressure-lowering procedure.

Pars plana vitrectomy may be useful for persistent vitreous opacities, diagnostic sampling, or selected posterior segment complications.

Long-acting intraocular corticosteroid implants may be considered in selected patients with chronic noninfectious posterior uveitis, but they carry substantial risks of cataract and glaucoma.

Inpatient Considerations

Hospitalization is usually unnecessary when disease is confined to the eye.

Admission may occasionally be required for serious systemic infection or when intravenous therapy is needed, such as selected cases of neurosyphilis or severe viral retinitis.

Follow-Up

Patients should be followed closely while inflammation remains active.

The frequency of examination depends on the severity, location, underlying cause, and treatment being used.

Corticosteroids should be tapered slowly as inflammation resolves to minimize rebound disease.

After remission, patients require periodic ophthalmic evaluation because recurrence is common.

Patient Monitoring

Monitoring should include visual acuity, intraocular pressure, anterior chamber inflammation, vitreous activity, retinal and choroidal findings, and macular status.

Patients taking systemic corticosteroids or immunosuppressive medications also require appropriate systemic laboratory and clinical monitoring.

Patient Education

Patients should understand that granulomatous uveitis may be chronic or recurrent.

They should seek prompt evaluation for recurrence of redness, pain, photophobia, floaters, or decreased vision.

They should also understand the importance of following a prescribed corticosteroid taper rather than stopping treatment abruptly.

Untreated or inadequately treated inflammation can result in permanent visual loss.

Prognosis

The visual prognosis depends on the underlying etiology, severity and duration of inflammation, response to treatment, and development of complications.

Many patients maintain good visual function when the cause is identified and the inflammation is appropriately controlled.

The prognosis becomes less favorable when there is cataract, glaucoma, chronic cystoid macular edema, retinal or choroidal scarring, or recurrent severe inflammation.

Complications

Important complications include cataract, secondary glaucoma, cystoid macular edema, exudative retinal detachment, retinal pigment epithelial atrophy, posterior synechiae, band keratopathy, and permanent visual impairment.

Ophthalmology– Goldenhar Syndrome

Basics

Description

Goldenhar syndrome is a congenital craniofacial disorder within the oculo-auriculo-vertebral spectrum (OAVS). It is characterized by a variable combination of epibulbar choristomas, preauricular skin tags or appendages, vertebral abnormalities, and hemifacial microsomia.

The abnormalities usually involve structures derived from the first and second branchial arches. Ocular involvement is common and may affect the conjunctiva, cornea, eyelids, lacrimal system, ocular motility, and visual development.

Epidemiology

Goldenhar syndrome occurs in approximately 1 in 3,500 to 5,600 births. Males are affected somewhat more frequently than females.

The severity and combination of abnormalities vary widely among affected individuals.

Risk Factors

No definitive environmental or maternal risk factor has been established.

Most cases occur sporadically.

Genetics

Most individuals with Goldenhar syndrome have no affected family members.

Both autosomal dominant and autosomal recessive inheritance have occasionally been reported. Familial cases with bilateral auricular involvement may be more suggestive of inherited disease.

Several chromosomal abnormalities have been associated with the phenotype, including abnormalities involving 5p and 22q11.2.

A number of genetic loci have been proposed, and mutations involving SALL1 have been identified in some patients with overlapping phenotypes.

Because the genetic basis is heterogeneous, genetic evaluation is useful when there are atypical findings, multiple affected relatives, or associated systemic abnormalities.

Pathophysiology

Goldenhar syndrome is believed to result from abnormal embryologic development affecting the first and second pharyngeal arches.

One proposed mechanism is impaired migration or development of neural crest cells, which contribute to formation of the craniofacial skeleton, connective tissues, and other structures.

Disruption of these developmental pathways produces variable abnormalities of the maxilla, mandible, ears, vertebrae, eyelids, and ocular surface.

Etiology

The exact etiology is heterogeneous and incompletely understood.

Abnormal development of neural crest-derived structures and the first and second branchial arches is believed to be central to the disorder.

The ocular abnormalities are related particularly to abnormal development of tissues derived from the first branchial arch and adjacent craniofacial structures.

Commonly Associated Conditions

The characteristic craniofacial finding is hemifacial microsomia, in which one side of the face is underdeveloped.

Auricular abnormalities are common and may include microtia, malformed external ears, preauricular appendages, and hearing loss or deafness.

Vertebral abnormalities may cause scoliosis or torticollis.

Other patients have associated cardiovascular, neurologic, musculoskeletal, renal, or genitourinary abnormalities.

Nasal and airway abnormalities may also occur.

Diagnosis

History

A detailed family history should be obtained, with attention to craniofacial abnormalities, hearing loss, ear deformities, vertebral abnormalities, and similar ocular findings.

Developmental history and symptoms related to hearing, breathing, feeding, renal function, or neurologic problems should also be reviewed.

Ophthalmic Examination

A complete ophthalmic examination is essential because several abnormalities can interfere with visual development.

Epibulbar Dermoid

The most common ocular finding is an epibulbar or limbal dermoid.

It is classically located in the inferotemporal limbal region and is usually ipsilateral to the more severely affected side of the face.

The lesion is a congenital choristoma composed of normal tissue located in an abnormal position. It can contain hair follicles and occasionally protruding cilia.

A large limbal dermoid can distort the corneal curvature and cause significant astigmatism, which may lead to amblyopia.

Lipodermoid

A lipodermoid, or dermolipoma, is another common choristoma.

It is usually located temporally, often in the superotemporal or lateral conjunctival fornix. It may extend posteriorly toward orbital tissues and extraocular muscles.

Strabismus and Ocular Motility

Ocular alignment and motility should be carefully assessed.

Duane syndrome and other ocular motility disturbances have been associated with Goldenhar syndrome.

Strabismus itself may contribute to amblyopia.

Eyelid Abnormalities

An upper eyelid coloboma may occur and can sometimes be associated with adhesion between the eyelid and globe.

Other less common abnormalities include ptosis and shortening or distortion of the palpebral fissure.

If an eyelid coloboma prevents adequate ocular surface coverage, exposure-related corneal damage may occur.

Lacrimal Abnormalities

Congenital anomalies of the lacrimal drainage system may occur and can produce chronic tearing or recurrent infection.

Corneal Sensation and Tear Production

Some patients have decreased corneal sensation or reduced tear production.

When severe, these abnormalities can lead to neurotrophic or exposure-related corneal ulceration.

Microphthalmia and Posterior Segment Findings

Less commonly, patients may have microphthalmia, optic nerve hypoplasia, or macular hypoplasia.

The caruncle can also be absent, displaced, or otherwise abnormal.

Visual Assessment

Visual acuity should be assessed using age-appropriate techniques.

Particular attention should be paid to refractive error and amblyopia, because limbal dermoids can induce significant astigmatism even when the lesion itself does not obstruct the visual axis.

Cycloplegic refraction is therefore important in children.

Systemic Examination

A complete systemic evaluation should assess for facial asymmetry, mandibular and maxillary hypoplasia, preauricular appendages, microtia, vertebral abnormalities, hearing impairment, cardiac defects, and renal abnormalities.

Because the syndrome is multisystem, evaluation frequently requires several specialties.

Diagnostic Tests and Interpretation

Laboratory Testing

Routine laboratory testing is not required when the syndrome is isolated and the diagnosis is clinically evident.

Laboratory evaluation should be directed by associated systemic findings, particularly when renal or genitourinary abnormalities are suspected.

Imaging

Facial and neurologic imaging may be obtained when significant craniofacial abnormalities are present.

Cervical spine imaging is often useful because vertebral abnormalities are an important component of the syndrome.

CT or MRI may be indicated depending on associated craniofacial, neurologic, or orbital abnormalities.

Audiology

All affected patients should undergo appropriate hearing assessment, because hearing impairment is common and may substantially affect language development.

Renal Evaluation

A renal ultrasound may be appropriate when there are clinical findings suggesting renal involvement or as part of a broader syndromic evaluation.

Genetic Evaluation

Genetics consultation can assist with diagnosis, identification of associated syndromes, selection of molecular or chromosomal testing, and recurrence counseling.

Pathological Findings

Epibulbar dermoids contain collagenous connective tissue covered by conjunctival or corneal epithelium.

They may contain skin appendages such as hair follicles, sebaceous glands, or sweat glands, reflecting their choristomatous nature.

Differential Diagnosis

Conditions with overlapping craniofacial abnormalities include Treacher Collins syndrome, Pierre Robin sequence, Townes-Brocks syndrome, oculoectodermal syndrome, and other craniofacial or branchial arch disorders.

The characteristic combination of epibulbar dermoid, ear abnormalities, hemifacial microsomia, and vertebral defects strongly supports the diagnosis of Goldenhar syndrome.

Treatment

There is no medication that treats the underlying congenital disorder.

Management is directed toward preserving vision, correcting associated abnormalities, and treating systemic complications.

Amblyopia Treatment

Amblyopia should be treated promptly when present.

This may involve full correction of refractive error, patching, or other standard amblyopia therapy.

Because astigmatism induced by a limbal dermoid is a common cause of amblyopia, accurate optical correction is particularly important.

Surgical Treatment

Limbal Dermoid

Surgical excision of a limbal dermoid may be considered when there is significant cosmetic concern, chronic irritation, foreign-body sensation, induced astigmatism contributing to amblyopia, progressive corneal involvement, or other corneal complications.

Surgery does not always eliminate the induced astigmatism, so refractive and amblyopia treatment may still be required afterward.

Depending on the depth and size of the lesion, ocular surface reconstruction or corneal procedures may be necessary.

Lipodermoid

Lipodermoid excision should be approached cautiously.

These lesions may extend deeply and can lie close to extraocular muscles, the lacrimal gland, and orbital structures. Aggressive removal can cause restrictive strabismus, scarring, or other complications.

Therefore, only the symptomatic or cosmetically significant accessible portion may be removed in selected cases.

Eyelid Surgery

Eyelid colobomas, ptosis, and other lid abnormalities may require reconstructive surgery, particularly when the cornea is exposed or the visual axis is obstructed.

Craniofacial Surgery

Craniofacial and plastic surgical procedures may be required for significant hemifacial microsomia, mandibular hypoplasia, auricular abnormalities, or other facial malformations.

Treatment is often staged according to growth and functional needs.

Referral

Management is frequently multidisciplinary.

Patients may require referral to ophthalmology, pediatric ophthalmology, craniofacial or plastic surgery, otolaryngology, audiology, genetics, orthodontics, oral and maxillofacial surgery, and other specialties according to the associated abnormalities.

Ongoing Care and Follow-Up

Children require regular ophthalmologic follow-up to monitor visual acuity, refractive error, amblyopia, strabismus, corneal health, and growth or symptoms related to choristomas.

A limbal dermoid that remains stable and asymptomatic may be observed, but refractive effects should still be monitored carefully.

Hearing, craniofacial development, vertebral abnormalities, and associated systemic conditions should also be followed by the appropriate specialists.

Patient Education

Families should understand that Goldenhar syndrome has a wide spectrum of severity and that not every affected child develops all associated abnormalities.

The importance of early treatment of refractive error and amblyopia should be emphasized because visual loss from amblyopia may be preventable.

Children with hearing impairment should receive early audiologic intervention and appropriate educational support.

Genetic counseling may help families understand the usually sporadic nature of the disorder and the possibility of recurrence in familial cases.

Prognosis

The ocular prognosis is generally good when amblyopia, refractive error, exposure, and strabismus are recognized and treated early.

Visual outcome may be less favorable when significant microphthalmia, optic nerve hypoplasia, macular abnormalities, or severe corneal disease is present.

Overall prognosis depends largely on the severity of associated craniofacial and systemic abnormalities.

Complications

Ocular complications include amblyopia, significant astigmatism, strabismus, corneal dellen, exposure keratopathy, neurotrophic corneal disease, and corneal ulceration.

Large or symptomatic choristomas may cause chronic irritation or progressive corneal distortion.

Associated hearing impairment and craniofacial abnormalities can also substantially affect development and quality of life if they are not identified and managed early.

Ophthalmology – Giant Cell Arteritis

Basics

Description

Giant cell arteritis (GCA), also called temporal arteritis, is a systemic inflammatory vasculitis involving predominantly medium- and large-sized arteries. Inflammation within the arterial wall causes intimal proliferation, progressive narrowing of the vascular lumen, and ultimately tissue ischemia.

GCA is one of the most important ophthalmic emergencies because it can produce sudden, severe, and usually irreversible visual loss. Once one eye is affected, the fellow eye is at substantial risk if treatment is not started immediately. Systemic glucocorticoid therapy therefore should not be delayed while awaiting confirmatory testing when clinical suspicion is high. 

The most common ocular cause of visual loss is arteritic anterior ischemic optic neuropathy (AAION). Other ocular ischemic manifestations include central or branch retinal artery occlusion, cilioretinal artery occlusion, posterior ischemic optic neuropathy, and ocular ischemic syndrome.

Epidemiology

GCA occurs almost exclusively in adults older than 50 years and becomes increasingly common with advancing age. Women are affected more frequently than men, and the disease is particularly common in individuals of Northern European or Scandinavian ancestry. 

Genetic susceptibility appears to contribute to disease risk. Associations with particular HLA class II alleles, especially HLA-DRB1 variants, have been described, although GCA is not a simple Mendelian genetic disorder.

Prevention

There is no established method for preventing the development of GCA.

The major preventable complication is permanent visual loss, and prevention depends on recognizing the disease promptly and initiating adequate glucocorticoid therapy before irreversible ischemic injury occurs.

Pathophysiology

Both the innate and adaptive immune systems contribute to GCA.

Activation of dendritic cells within susceptible arterial walls promotes recruitment and activation of CD4-positive T lymphocytes and macrophages. These cells release inflammatory cytokines and organize into a granulomatous inflammatory response.

Macrophages and multinucleated giant cells may accumulate near the internal elastic lamina and contribute to destruction of the arterial wall.

Cytokines such as interleukin-6 contribute to the systemic acute-phase response, producing elevated inflammatory markers and constitutional symptoms.

Progressive inflammation produces intimal hyperplasia, luminal stenosis, thrombosis, and vascular occlusion, resulting in ischemia of structures supplied by the affected arteries.

Etiology

The precise cause of GCA remains unknown.

It is thought to develop in genetically susceptible older individuals after inappropriate activation of the immune system. Infectious triggers have been proposed, but no single infectious organism has been established as the cause.

Commonly Associated Conditions

GCA is strongly associated with polymyalgia rheumatica (PMR).

PMR typically causes bilateral aching and morning stiffness involving the shoulder girdle, neck, hips, and pelvic girdle. The two conditions can occur independently or together.

Diagnosis

History

Patients older than 50 years with possible GCA should be specifically questioned about systemic, cranial, and visual symptoms.

Constitutional manifestations may include fatigue, malaise, fever, decreased appetite, night sweats, and unintentional weight loss.

A new-onset or substantially changed headache is a common presenting symptom. The headache may be temporal but can occur elsewhere.

Patients may describe scalp tenderness, such as discomfort when brushing their hair or resting the head on a pillow.

Jaw claudication is particularly suggestive of GCA. Patients describe aching or fatigue of the jaw muscles when chewing that improves with rest. Tongue claudication and facial pain occur less frequently.

Symptoms of associated polymyalgia rheumatica include proximal muscle aching and marked morning stiffness.

Visual Symptoms

Visual manifestations require urgent attention.

Patients may experience transient monocular visual loss, episodes of dimming or graying of vision, diplopia, or sudden permanent visual loss.

Importantly, some patients with ocular GCA have few or no constitutional symptoms. Therefore, the absence of headache, jaw claudication, fever, or polymyalgia symptoms does not exclude the diagnosis.

Physical Examination

Temporal Arteries

The temporal arteries should be examined for tenderness, thickening, nodularity, reduced pulsation, or absence of pulse.

A normal temporal artery examination does not exclude GCA.

Arteritic Anterior Ischemic Optic Neuropathy

The classic ophthalmic manifestation is AAION.

The optic disc is typically markedly swollen and often has a characteristic pale or chalky-white appearance, in contrast to the more frequently hyperemic disc swelling seen in nonarteritic anterior ischemic optic neuropathy.

Visual acuity may be profoundly reduced. A relative afferent pupillary defect, dyschromatopsia, and severe visual-field loss are common when involvement is unilateral or asymmetric.

Later, the optic disc becomes pale and atrophic.

Retinal Arterial Occlusion

GCA can cause central, branch, or cilioretinal artery occlusion.

When an older patient develops retinal arterial occlusion without an obvious embolic source, especially in association with systemic symptoms or elevated inflammatory markers, GCA must be considered urgently.

Diplopia

Transient or persistent diplopia may result from ischemia affecting the third, fourth, or sixth cranial nerve or their vascular supply.

Diagnostic Tests and Interpretation

Inflammatory Markers

There is no single laboratory test that definitively confirms or excludes GCA.

The initial laboratory evaluation typically includes erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), complete blood count, and platelet count.

Most patients have elevated ESR and CRP, but normal inflammatory markers can occasionally occur. Consequently, a normal ESR alone must never be used to exclude GCA when the clinical presentation is strongly suggestive.

CRP is often particularly useful because it responds rapidly to systemic inflammation and is less strongly influenced by factors such as age and anemia.

Thrombocytosis and a normocytic anemia may provide additional supportive evidence.

Vascular Ultrasound

Modern practice increasingly uses vascular ultrasonography in the initial evaluation of suspected GCA when appropriate expertise is available.

The updated EULAR imaging recommendations identify ultrasound of the temporal and axillary arteries as the first-line imaging test in suspected GCA, with characteristic findings including arterial wall thickening and the hypoechoic “halo” sign. 

Ultrasound is operator dependent and should ideally be performed rapidly because glucocorticoid therapy can reduce inflammatory imaging findings.

Temporal Artery Biopsy

Temporal artery biopsy (TAB) remains an important method of confirming cranial GCA, particularly where vascular ultrasound expertise is limited or when imaging is inconclusive.

Biopsy should not delay treatment in a patient with threatened or established visual loss.

The ACR/Vasculitis Foundation guideline favors obtaining an adequate biopsy specimen and recommends biopsy relatively soon after glucocorticoid initiation when used diagnostically. 

Because GCA can produce skip lesions, a negative biopsy does not completely exclude the disease.

If the biopsy is negative but clinical suspicion remains high, additional vascular imaging or evaluation of the contralateral temporal artery may be appropriate.

Large-Vessel Imaging

GCA can involve the aorta and its major branches in addition to the cranial arteries.

Depending on the clinical presentation, CT angiography, MR angiography, PET imaging, or vascular ultrasound may be used to identify extracranial large-vessel involvement. Current guidelines recognize vascular imaging as an important component of diagnosis and assessment. 

Fluorescein Angiography

In patients with suspected ocular ischemia, fluorescein angiography may show delayed or patchy choroidal filling, prolonged retinal arterial filling, and areas of choroidal nonperfusion.

These findings can support the diagnosis of arteritic ischemic optic neuropathy but do not replace systemic evaluation for GCA.

Pathological Findings

Temporal artery biopsy classically demonstrates granulomatous inflammation involving the arterial wall, often with lymphocytes, macrophages, and multinucleated giant cells.

Giant cells are characteristic but not required for the diagnosis.

Disruption of the internal elastic lamina, intimal thickening, and luminal narrowing may be present.

Inflammation may occur in discontinuous segments, producing the characteristic skip lesions.

Differential Diagnosis

The major ophthalmic differential diagnosis is nonarteritic anterior ischemic optic neuropathy (NAION).

Compared with NAION, AAION generally occurs in an older patient, produces more profound visual loss, and is more likely to show markedly pale or chalky optic disc swelling.

Other conditions that may mimic portions of the clinical syndrome include other vasculitides, infectious diseases, compressive optic neuropathy, retinal vascular occlusion from embolic disease, and inflammatory optic neuropathies.

Treatment

GCA is a medical and ophthalmic emergency when visual symptoms are present.

The primary goal is to prevent additional ischemic injury, particularly blindness in the fellow eye, stroke, and other vascular complications.

Glucocorticoid Treatment

High-dose systemic glucocorticoids remain the foundation of initial therapy. Treatment should begin immediately when GCA is strongly suspected and should not wait for biopsy or imaging confirmation. 

For patients without visual ischemia, current guidelines recommend high-dose oral glucocorticoid therapy, with the precise regimen individualized to clinical circumstances. 

For patients with threatened or established visual loss or other cranial ischemic complications, pulse intravenous glucocorticoids such as methylprednisolone are commonly used initially, followed by high-dose oral glucocorticoid therapy. The ACR/Vasculitis Foundation guideline conditionally favors IV pulse glucocorticoids in patients with threatened vision loss. 

Tocilizumab and Steroid-Sparing Therapy

Modern treatment increasingly incorporates tocilizumab, an interleukin-6 receptor inhibitor, to reduce relapse and cumulative glucocorticoid exposure.

The ACR/Vasculitis Foundation guideline conditionally recommends tocilizumab plus glucocorticoids over glucocorticoids alone for many patients with newly diagnosed GCA. 

Methotrexate may be considered as an alternative steroid-sparing agent in selected patients, particularly when tocilizumab is unsuitable.

Treatment decisions should generally involve rheumatology or another physician experienced in systemic vasculitis.

Glucocorticoid Taper

Once disease control has been achieved, glucocorticoids are gradually tapered.

The taper must be individualized according to symptoms, inflammatory markers, recurrence risk, treatment-related toxicity, and use of steroid-sparing therapy.

EULAR guidance recommends reducing glucocorticoids progressively after remission rather than maintaining prolonged high doses; many patients still require treatment for an extended period. 

Rapid tapering can precipitate relapse.

Management of Glucocorticoid Complications

Because affected patients are usually older and may require prolonged treatment, complications of glucocorticoids are clinically important.

Patients require assessment and prevention of osteoporosis, hyperglycemia or diabetes, hypertension, infection, gastrointestinal complications, weight gain, mood disturbance, sleep disruption, cataract, and glaucoma.

Calcium and vitamin D supplementation, osteoporosis risk assessment, and additional bone-protective therapy may be appropriate depending on individual risk.

Referral

Patients with suspected ocular GCA require immediate ophthalmologic evaluation and urgent systemic treatment.

Rheumatology or internal medicine involvement is important for confirmation of the diagnosis, glucocorticoid tapering, steroid-sparing therapy, and monitoring of systemic vascular disease.

Patients with substantial visual impairment may benefit from low-vision rehabilitation.

Ongoing Care and Follow-Up

Follow-up should assess both disease activity and treatment toxicity.

Patients should be questioned repeatedly about recurrence of headache, scalp tenderness, jaw claudication, polymyalgia symptoms, constitutional symptoms, transient visual disturbances, or new visual loss.

ESR and CRP can be useful in monitoring many patients, but clinical assessment remains essential. This is particularly important in patients receiving tocilizumab because IL-6 blockade can suppress CRP and ESR even when clinical disease assessment remains necessary.

Large-vessel disease may require periodic vascular imaging depending on the initial pattern of arterial involvement and subsequent clinical course.

Patient Education

Patients should understand that recurrent symptoms can indicate disease relapse even while taking treatment.

They should seek immediate medical attention for any new transient or permanent visual disturbance, including dimming, graying, a curtain over the vision, or diplopia.

They should also report recurrent headache, scalp tenderness, jaw pain with chewing, or symptoms of polymyalgia rheumatica.

The adverse effects of long-term glucocorticoid therapy and the importance of medication adherence and laboratory monitoring should be carefully explained.

Prognosis

The prognosis for recovery of vision after established arteritic ischemic optic neuropathy is poor. Treatment is primarily intended to prevent further deterioration and protect the fellow eye rather than restore already infarcted optic nerve tissue.

Visual deterioration can occasionally continue during the first days after treatment is started, emphasizing the importance of rapid recognition and therapy.

Without treatment, the risk of sequential involvement of the fellow eye is very high. Prompt systemic glucocorticoids dramatically reduce this risk.

The systemic prognosis is generally favorable with appropriate treatment, although relapses are common and patients require long-term monitoring.

Complications

The principal ophthalmic complications are permanent severe visual loss from AAION, retinal arterial occlusion, posterior ischemic optic neuropathy, and bilateral blindness.

Systemic vascular complications include ischemic stroke, aortic aneurysm or dissection, myocardial ischemia, and less commonly mesenteric ischemia.

Treatment itself can cause substantial morbidity through long-term glucocorticoid exposure, making careful steroid tapering and the use of appropriate steroid-sparing therapies important components of modern management. 

Ophthalmology – Fuchs’ Heterochromic Iridocyclitis

Basics

Description

Fuchs’ heterochromic iridocyclitis (FHI), also called Fuchs uveitis syndrome, is a chronic, usually unilateral, low-grade anterior uveitis characterized by diffuse iris atrophy, heterochromia, fine stellate keratic precipitates, and minimal external inflammation.

The condition is often relatively asymptomatic. Patients may have only mild blurred vision or floaters, and the eye is typically white and quiet, without the marked pain, photophobia, and redness seen in many other forms of anterior uveitis.

Although traditionally considered unilateral, bilateral disease is recognized and may make heterochromia less obvious.

A strong association exists between FHI and rubella virus, and chronic intraocular immune responses to rubella antigens are thought to play an important etiologic role.

Two major long-term complications are cataract and secondary glaucoma.

Epidemiology

FHI accounts for a relatively small proportion of anterior uveitis cases. It has been estimated to represent less than approximately 6% of anterior uveitis seen in tertiary referral settings.

Its true prevalence may be underestimated because many patients have minimal symptoms and may remain undiagnosed until they develop cataract, glaucoma, or vitreous opacities.

The frequency of FHI has declined in populations with widespread rubella vaccination, particularly among individuals born after introduction of routine childhood immunization programs.

Risk Factors

A history of lack of rubella vaccination or residence in a region without an effective rubella vaccination program may increase risk.

Because the disease may be nearly asymptomatic, patients who do not receive routine eye examinations may not be diagnosed until complications such as advanced glaucoma or visually significant cataract have developed.

No consistent genetic predisposition has been established.

Prevention

The principal preventive strategy is universal rubella vaccination.

Vaccination reduces circulation of rubella virus and appears to reduce the incidence of Fuchs uveitis syndrome in immunized populations.

Pediatric Considerations

FHI is less common among children born after widespread adoption of rubella vaccination.

When the condition is diagnosed in a child or young adult, the patient’s and maternal rubella vaccination history may be relevant.

Pregnancy Considerations

In a pregnant patient with clinical findings compatible with FHI, assessment of rubella immunity is important because primary rubella infection during pregnancy, especially early gestation, can cause congenital rubella syndrome.

The presence of FHI itself does not mean that the patient has an acute systemic rubella infection.

Pathophysiology

Fuchs uveitis syndrome is thought to result from a chronic, localized intraocular immune response, frequently associated with persistent exposure to rubella viral antigens.

A predominantly CD8-positive T-cell-mediated immune response has been demonstrated within the eye.

This chronic low-grade inflammation results in progressive iris stromal atrophy, characteristic keratic precipitates, abnormalities of the anterior chamber angle vessels, and eventually complications such as cataract and glaucoma.

Unlike many other forms of anterior uveitis, the inflammatory response is usually mild and does not typically produce posterior synechiae.

Etiology

Evidence strongly supports an association with rubella virus.

Intraocular production of rubella-specific antibodies has been detected in a high proportion of patients with the classic clinical syndrome.

Rubella viral RNA has also been detected in some ocular samples, especially in younger patients.

The disease is therefore thought to represent a chronic ocular immune response related to prior rubella infection rather than active systemic rubella disease.

Commonly Associated Conditions

The two most important associated ocular complications are cataract and glaucoma.

Cataract develops in a substantial proportion of affected eyes, often becoming the major cause of reduced vision.

Secondary glaucoma occurs less frequently but may be difficult to control and can cause permanent optic nerve damage.

Vitreous opacities are also common and can produce symptomatic floaters or reduced visual quality.

Diagnosis

History

Patients are commonly young or middle-aged and may be asymptomatic.

When symptoms occur, they may include mild unilateral blurred vision, gradual change in iris color, floaters, or mild ocular discomfort.

Severe pain, marked photophobia, and prominent redness are unusual and should raise suspicion for another diagnosis.

Some patients first present because of progressive visual loss from cataract or glaucoma.

Physical Examination

External Appearance

The affected eye usually appears white and quiet, despite the presence of chronic intraocular inflammation.

This absence of prominent conjunctival injection is an important diagnostic clue.

Heterochromia

Iris heterochromia is common.

In patients with dark irides, the affected eye typically appears lighter because of progressive iris stromal atrophy.

In patients with light-colored irides, the affected eye may paradoxically appear darker because thinning of the anterior iris stroma allows greater visualization of the underlying pigment epithelium.

In bilateral disease, obvious heterochromia may be absent.

Keratic Precipitates

A characteristic finding is the presence of diffuse, fine, stellate, nongranulomatous keratic precipitates distributed widely over the corneal endothelium.

Unlike the inferiorly concentrated keratic precipitates seen in many other forms of anterior uveitis, those in FHI are often diffusely distributed.

Anterior Chamber

A mild chronic anterior chamber cellular reaction may be present.

Inflammation is usually low grade.

Posterior synechiae are typically absent, which is a useful distinguishing feature from many other chronic anterior uveitides.

Peripheral anterior synechiae are also not characteristic.

Iris Atrophy

Diffuse iris stromal atrophy is typical and contributes to heterochromia.

The iris architecture may become less distinct over time.

Anterior Chamber Angle

Gonioscopy may demonstrate abnormal fine vessels crossing or bridging the anterior chamber angle.

These fragile vessels are clinically important because they may bleed during surgery or other intraocular manipulation.

Cataract

Cataract is a very common long-term complication and may become the principal cause of visual impairment.

Glaucoma

Secondary glaucoma may develop and requires careful long-term monitoring because FHI is often asymptomatic.

Vitreous

Vitreous cells and opacities are common and may cause floaters or reduced visual quality.

Posterior segment disease is otherwise uncommon, although occasional chorioretinal scars or cystoid macular edema may occur.

Diagnostic Tests and Interpretation

Clinical Diagnosis

In many patients, the diagnosis can be made from the characteristic clinical pattern of:

quiet eye + diffuse stellate keratic precipitates + iris atrophy or heterochromia + absence of posterior synechiae + vitreous involvement.

Not every finding is present simultaneously, so repeated examinations may be helpful.

Intraocular Rubella Antibody Testing

When the diagnosis is uncertain, analysis of aqueous humor for intraocular rubella antibody production can provide strong laboratory support.

A modified Goldmann–Witmer coefficient or antibody index may be used to compare intraocular and serum rubella-specific antibody levels.

Detection of significant intraocular rubella antibody production strongly supports FHI, while absence of such antibody makes the diagnosis less likely in a clinically ambiguous case.

This testing is generally reserved for selected patients rather than routinely performed in every classic case.

Oligoclonal IgG

Intraocular oligoclonal IgG has been reported in FHI, but it is not specific enough to replace clinical diagnosis or pathogen-directed antibody testing.

Photography

External and slit-lamp photography may be useful to document heterochromia, iris atrophy, cataract progression, and other structural changes.

Pathological Findings

Histopathologic specimens demonstrate lymphocytes and plasma cells, supporting the concept of a chronic immune-mediated response.

These findings are consistent with persistent viral antigen-driven intraocular inflammation.

Differential Diagnosis

The differential diagnosis includes other causes of chronic unilateral anterior uveitis, especially herpes simplex virus, varicella-zoster virus, toxoplasmosis-associated uveitis, and Posner–Schlossman syndrome.

Herpetic anterior uveitis may produce elevated intraocular pressure and iris atrophy but is more likely to show sectoral rather than diffuse iris atrophy and may be associated with corneal disease.

Posner–Schlossman syndrome is characterized by recurrent episodes of markedly elevated intraocular pressure with relatively mild inflammation, but it does not typically produce the full classic picture of diffuse iris atrophy and stellate keratic precipitates.

Other causes of heterochromia include Horner syndrome and iris melanoma.

The absence of posterior synechiae despite chronic inflammation is particularly supportive of FHI.

Treatment

Inflammation

Unlike most forms of anterior uveitis, chronic low-grade inflammation in FHI often does not require topical corticosteroid therapy.

Steroid drops may have limited effect on the underlying inflammation and can increase the risk of cataract formation and steroid-induced ocular hypertension or glaucoma.

Therefore, mild asymptomatic inflammation is often observed rather than chronically treated.

If significant inflammation occurs around ocular surgery or in an atypical exacerbation, short-term corticosteroid treatment may be appropriate.

Glaucoma

Secondary glaucoma should be treated aggressively because glaucomatous optic neuropathy is an important cause of permanent visual loss.

Initial treatment usually involves standard intraocular pressure-lowering medications.

Patients with poorly controlled pressure or progressive optic nerve or visual-field damage should be referred to a glaucoma specialist.

Surgical glaucoma treatment may ultimately be necessary.

Cataract Surgery

Cataract extraction can provide substantial visual improvement when the cataract is the major cause of reduced vision.

However, surgery may be complicated by bleeding from the fragile abnormal angle vessels.

A characteristic finding is Amsler sign, in which blood appears in the anterior chamber following paracentesis or intraocular manipulation because of rupture of these abnormal vessels.

Perioperative topical corticosteroids, and occasionally systemic anti-inflammatory therapy, may be used to limit surgery-induced inflammation.

Postoperative visual outcome may still be limited by glaucoma, vitreous opacities, posterior capsule opacification, or other ocular pathology.

Vitrectomy

Pars plana vitrectomy may be considered when dense or persistent vitreous opacities cause significant visual impairment.

This is generally reserved for patients whose symptoms cannot be explained by cataract or other anterior segment abnormalities.

Referral

Patients with uncontrolled intraocular pressure, progressive optic nerve damage, or worsening visual-field loss should be referred to a glaucoma specialist.

Referral to a uveitis specialist may be useful when the diagnosis is uncertain or when the clinical presentation is atypical.

Follow-Up

Because FHI is a chronic and frequently asymptomatic disease, regular ophthalmic follow-up is essential even when the patient feels well.

The interval depends largely on the presence and severity of glaucoma and cataract.

Follow-up should include assessment of visual acuity, intraocular pressure, optic nerve status, cataract progression, anterior chamber inflammation, and vitreous opacities.

Patients with glaucoma require appropriate optic nerve imaging and visual-field monitoring.

Patient Education

Patients should understand that the disease is usually chronic but often causes little discomfort.

They should be informed that lack of pain or redness does not mean the disease is inactive or harmless, because glaucoma can progress without symptoms.

Compliance with prescribed glaucoma therapy and scheduled follow-up is particularly important.

Patients should also understand that cataract is common but is generally treatable surgically.

Prognosis

The visual prognosis is generally good when glaucoma and cataract are recognized and treated appropriately.

Many patients maintain useful vision for many years.

The most important threat to irreversible vision loss is uncontrolled secondary glaucoma, whereas cataract-related vision loss is usually reversible with surgery.

Vitreous opacities and occasional posterior segment complications can also limit final vision.

Complications

Major complications include cataract, secondary glaucoma, vitreous opacities, and occasional cystoid macular edema.

Cataract or glaucoma surgery may be complicated by intraoperative or postoperative hyphema because of abnormal angle vessels.

Permanent visual loss is most likely when glaucoma is diagnosed late or remains inadequately controlled.

Ophthalmology – Fuchs’ Heterochromic Iridocyclitis

Basics

Description

Fuchs’ heterochromic iridocyclitis (FHI), also called Fuchs uveitis syndrome, is a chronic, usually unilateral, low-grade anterior uveitis characterized by diffuse iris atrophy, heterochromia, fine stellate keratic precipitates, and minimal external inflammation.

The condition is often relatively asymptomatic. Patients may have only mild blurred vision or floaters, and the eye is typically white and quiet, without the marked pain, photophobia, and redness seen in many other forms of anterior uveitis.

Although traditionally considered unilateral, bilateral disease is recognized and may make heterochromia less obvious.

A strong association exists between FHI and rubella virus, and chronic intraocular immune responses to rubella antigens are thought to play an important etiologic role.

Two major long-term complications are cataract and secondary glaucoma.

Epidemiology

FHI accounts for a relatively small proportion of anterior uveitis cases. It has been estimated to represent less than approximately 6% of anterior uveitis seen in tertiary referral settings.

Its true prevalence may be underestimated because many patients have minimal symptoms and may remain undiagnosed until they develop cataract, glaucoma, or vitreous opacities.

The frequency of FHI has declined in populations with widespread rubella vaccination, particularly among individuals born after introduction of routine childhood immunization programs.

Risk Factors

A history of lack of rubella vaccination or residence in a region without an effective rubella vaccination program may increase risk.

Because the disease may be nearly asymptomatic, patients who do not receive routine eye examinations may not be diagnosed until complications such as advanced glaucoma or visually significant cataract have developed.

No consistent genetic predisposition has been established.

Prevention

The principal preventive strategy is universal rubella vaccination.

Vaccination reduces circulation of rubella virus and appears to reduce the incidence of Fuchs uveitis syndrome in immunized populations.

Pediatric Considerations

FHI is less common among children born after widespread adoption of rubella vaccination.

When the condition is diagnosed in a child or young adult, the patient’s and maternal rubella vaccination history may be relevant.

Pregnancy Considerations

In a pregnant patient with clinical findings compatible with FHI, assessment of rubella immunity is important because primary rubella infection during pregnancy, especially early gestation, can cause congenital rubella syndrome.

The presence of FHI itself does not mean that the patient has an acute systemic rubella infection.

Pathophysiology

Fuchs uveitis syndrome is thought to result from a chronic, localized intraocular immune response, frequently associated with persistent exposure to rubella viral antigens.

A predominantly CD8-positive T-cell-mediated immune response has been demonstrated within the eye.

This chronic low-grade inflammation results in progressive iris stromal atrophy, characteristic keratic precipitates, abnormalities of the anterior chamber angle vessels, and eventually complications such as cataract and glaucoma.

Unlike many other forms of anterior uveitis, the inflammatory response is usually mild and does not typically produce posterior synechiae.

Etiology

Evidence strongly supports an association with rubella virus.

Intraocular production of rubella-specific antibodies has been detected in a high proportion of patients with the classic clinical syndrome.

Rubella viral RNA has also been detected in some ocular samples, especially in younger patients.

The disease is therefore thought to represent a chronic ocular immune response related to prior rubella infection rather than active systemic rubella disease.

Commonly Associated Conditions

The two most important associated ocular complications are cataract and glaucoma.

Cataract develops in a substantial proportion of affected eyes, often becoming the major cause of reduced vision.

Secondary glaucoma occurs less frequently but may be difficult to control and can cause permanent optic nerve damage.

Vitreous opacities are also common and can produce symptomatic floaters or reduced visual quality.

Diagnosis

History

Patients are commonly young or middle-aged and may be asymptomatic.

When symptoms occur, they may include mild unilateral blurred vision, gradual change in iris color, floaters, or mild ocular discomfort.

Severe pain, marked photophobia, and prominent redness are unusual and should raise suspicion for another diagnosis.

Some patients first present because of progressive visual loss from cataract or glaucoma.

Physical Examination

External Appearance

The affected eye usually appears white and quiet, despite the presence of chronic intraocular inflammation.

This absence of prominent conjunctival injection is an important diagnostic clue.

Heterochromia

Iris heterochromia is common.

In patients with dark irides, the affected eye typically appears lighter because of progressive iris stromal atrophy.

In patients with light-colored irides, the affected eye may paradoxically appear darker because thinning of the anterior iris stroma allows greater visualization of the underlying pigment epithelium.

In bilateral disease, obvious heterochromia may be absent.

Keratic Precipitates

A characteristic finding is the presence of diffuse, fine, stellate, nongranulomatous keratic precipitates distributed widely over the corneal endothelium.

Unlike the inferiorly concentrated keratic precipitates seen in many other forms of anterior uveitis, those in FHI are often diffusely distributed.

Anterior Chamber

A mild chronic anterior chamber cellular reaction may be present.

Inflammation is usually low grade.

Posterior synechiae are typically absent, which is a useful distinguishing feature from many other chronic anterior uveitides.

Peripheral anterior synechiae are also not characteristic.

Iris Atrophy

Diffuse iris stromal atrophy is typical and contributes to heterochromia.

The iris architecture may become less distinct over time.

Anterior Chamber Angle

Gonioscopy may demonstrate abnormal fine vessels crossing or bridging the anterior chamber angle.

These fragile vessels are clinically important because they may bleed during surgery or other intraocular manipulation.

Cataract

Cataract is a very common long-term complication and may become the principal cause of visual impairment.

Glaucoma

Secondary glaucoma may develop and requires careful long-term monitoring because FHI is often asymptomatic.

Vitreous

Vitreous cells and opacities are common and may cause floaters or reduced visual quality.

Posterior segment disease is otherwise uncommon, although occasional chorioretinal scars or cystoid macular edema may occur.

Diagnostic Tests and Interpretation

Clinical Diagnosis

In many patients, the diagnosis can be made from the characteristic clinical pattern of:

quiet eye + diffuse stellate keratic precipitates + iris atrophy or heterochromia + absence of posterior synechiae + vitreous involvement.

Not every finding is present simultaneously, so repeated examinations may be helpful.

Intraocular Rubella Antibody Testing

When the diagnosis is uncertain, analysis of aqueous humor for intraocular rubella antibody production can provide strong laboratory support.

A modified Goldmann–Witmer coefficient or antibody index may be used to compare intraocular and serum rubella-specific antibody levels.

Detection of significant intraocular rubella antibody production strongly supports FHI, while absence of such antibody makes the diagnosis less likely in a clinically ambiguous case.

This testing is generally reserved for selected patients rather than routinely performed in every classic case.

Oligoclonal IgG

Intraocular oligoclonal IgG has been reported in FHI, but it is not specific enough to replace clinical diagnosis or pathogen-directed antibody testing.

Photography

External and slit-lamp photography may be useful to document heterochromia, iris atrophy, cataract progression, and other structural changes.

Pathological Findings

Histopathologic specimens demonstrate lymphocytes and plasma cells, supporting the concept of a chronic immune-mediated response.

These findings are consistent with persistent viral antigen-driven intraocular inflammation.

Differential Diagnosis

The differential diagnosis includes other causes of chronic unilateral anterior uveitis, especially herpes simplex virus, varicella-zoster virus, toxoplasmosis-associated uveitis, and Posner–Schlossman syndrome.

Herpetic anterior uveitis may produce elevated intraocular pressure and iris atrophy but is more likely to show sectoral rather than diffuse iris atrophy and may be associated with corneal disease.

Posner–Schlossman syndrome is characterized by recurrent episodes of markedly elevated intraocular pressure with relatively mild inflammation, but it does not typically produce the full classic picture of diffuse iris atrophy and stellate keratic precipitates.

Other causes of heterochromia include Horner syndrome and iris melanoma.

The absence of posterior synechiae despite chronic inflammation is particularly supportive of FHI.

Treatment

Inflammation

Unlike most forms of anterior uveitis, chronic low-grade inflammation in FHI often does not require topical corticosteroid therapy.

Steroid drops may have limited effect on the underlying inflammation and can increase the risk of cataract formation and steroid-induced ocular hypertension or glaucoma.

Therefore, mild asymptomatic inflammation is often observed rather than chronically treated.

If significant inflammation occurs around ocular surgery or in an atypical exacerbation, short-term corticosteroid treatment may be appropriate.

Glaucoma

Secondary glaucoma should be treated aggressively because glaucomatous optic neuropathy is an important cause of permanent visual loss.

Initial treatment usually involves standard intraocular pressure-lowering medications.

Patients with poorly controlled pressure or progressive optic nerve or visual-field damage should be referred to a glaucoma specialist.

Surgical glaucoma treatment may ultimately be necessary.

Cataract Surgery

Cataract extraction can provide substantial visual improvement when the cataract is the major cause of reduced vision.

However, surgery may be complicated by bleeding from the fragile abnormal angle vessels.

A characteristic finding is Amsler sign, in which blood appears in the anterior chamber following paracentesis or intraocular manipulation because of rupture of these abnormal vessels.

Perioperative topical corticosteroids, and occasionally systemic anti-inflammatory therapy, may be used to limit surgery-induced inflammation.

Postoperative visual outcome may still be limited by glaucoma, vitreous opacities, posterior capsule opacification, or other ocular pathology.

Vitrectomy

Pars plana vitrectomy may be considered when dense or persistent vitreous opacities cause significant visual impairment.

This is generally reserved for patients whose symptoms cannot be explained by cataract or other anterior segment abnormalities.

Referral

Patients with uncontrolled intraocular pressure, progressive optic nerve damage, or worsening visual-field loss should be referred to a glaucoma specialist.

Referral to a uveitis specialist may be useful when the diagnosis is uncertain or when the clinical presentation is atypical.

Follow-Up

Because FHI is a chronic and frequently asymptomatic disease, regular ophthalmic follow-up is essential even when the patient feels well.

The interval depends largely on the presence and severity of glaucoma and cataract.

Follow-up should include assessment of visual acuity, intraocular pressure, optic nerve status, cataract progression, anterior chamber inflammation, and vitreous opacities.

Patients with glaucoma require appropriate optic nerve imaging and visual-field monitoring.

Patient Education

Patients should understand that the disease is usually chronic but often causes little discomfort.

They should be informed that lack of pain or redness does not mean the disease is inactive or harmless, because glaucoma can progress without symptoms.

Compliance with prescribed glaucoma therapy and scheduled follow-up is particularly important.

Patients should also understand that cataract is common but is generally treatable surgically.

Prognosis

The visual prognosis is generally good when glaucoma and cataract are recognized and treated appropriately.

Many patients maintain useful vision for many years.

The most important threat to irreversible vision loss is uncontrolled secondary glaucoma, whereas cataract-related vision loss is usually reversible with surgery.

Vitreous opacities and occasional posterior segment complications can also limit final vision.

Complications

Major complications include cataract, secondary glaucoma, vitreous opacities, and occasional cystoid macular edema.

Cataract or glaucoma surgery may be complicated by intraoperative or postoperative hyphema because of abnormal angle vessels.

Permanent visual loss is most likely when glaucoma is diagnosed late or remains inadequately controlled.

Ophthalmology – Fuchs’ Corneal Dystrophy

Basics

Description

Fuchs’ corneal dystrophy, more precisely called Fuchs endothelial corneal dystrophy (FECD), is a progressive, usually bilateral and noninflammatory disorder of the corneal endothelium. It is characterized by the formation of focal excrescences of Descemet membrane known as corneal guttae, progressive loss and dysfunction of endothelial cells, and subsequent stromal and epithelial corneal edema.

The corneal endothelium normally maintains corneal deturgescence by acting as both a permeability barrier and an active fluid pump. As endothelial cells become dysfunctional and decrease in number, the cornea gradually loses its ability to remain dehydrated and transparent.

Patients typically complain of blurred vision and glare that are worse in the morning after awakening. As disease progresses, epithelial edema may lead to formation of painful bullae. Rupture of these bullae can cause recurrent erosions, pain, photophobia, and tearing.

Epidemiology

Fuchs dystrophy most commonly becomes clinically significant in the fifth and sixth decades of life, although corneal guttae may be detected earlier.

A rare early-onset form can present during childhood or the first few decades of life.

Women are affected more commonly than men.

The prevalence of clinically apparent disease increases with age, and corneal guttae are relatively common in older adults.

Risk Factors

The strongest risk factor is increasing age.

Other factors that can worsen endothelial dysfunction include elevated intraocular pressure, ocular inflammation, and previous intraocular surgery, particularly cataract surgery.

Because patients with Fuchs dystrophy already have reduced endothelial reserve, additional endothelial cell loss during intraocular surgery can precipitate clinically significant corneal edema.

Genetics

Fuchs endothelial corneal dystrophy has a strong genetic component but is genetically heterogeneous.

Some families show autosomal dominant inheritance with incomplete penetrance and variable expression.

Several genetic loci and genes have been associated with FECD. Early-onset disease has been linked to mutations in COL8A2, while common late-onset disease is associated with other genetic abnormalities, including variants involving TCF4 in many populations.

Because expression can vary markedly even within the same family, relatives with the same pathogenic variant may have very different clinical severity.

Pathophysiology

The primary abnormality is progressive dysfunction and loss of corneal endothelial cells.

The diseased endothelium produces abnormal Descemet membrane, resulting in focal collagenous excrescences called guttae. Over time, Descemet membrane becomes abnormally thickened.

As endothelial cell density falls, the remaining cells enlarge and change shape in an attempt to cover the posterior corneal surface. These changes are described as polymegathism, meaning variation in cell size, and pleomorphism or polymorphism, meaning variation in cell shape.

Eventually, the endothelial barrier and pump functions become insufficient. Failure of the endothelial Na+/K+-ATPase-dependent fluid transport system allows fluid to accumulate in the corneal stroma.

Stromal edema initially develops posteriorly and then progresses anteriorly. With more advanced disease, the epithelium becomes edematous and develops microcysts that coalesce into epithelial bullae.

Chronic edema may eventually cause subepithelial fibrosis, anterior basement membrane abnormalities, corneal scarring, and superficial neovascularization.

Etiology

Endothelial cell density normally decreases throughout life. Patients with Fuchs dystrophy experience an accelerated and pathologic loss of endothelial cells.

In infancy, endothelial cell density is much higher than in adulthood. Because human corneal endothelial cells have very limited ability to regenerate, progressive cell loss gradually reduces endothelial reserve.

Additional endothelial injury from cataract surgery, other intraocular procedures, inflammation, trauma, or elevated intraocular pressure may accelerate decompensation.

Commonly Associated Conditions

Fuchs dystrophy is frequently associated with cataract, particularly because both conditions become more common with age.

Other associations include open-angle glaucoma, angle-closure glaucoma, recurrent epithelial erosions, and painful bullous keratopathy.

Keratoconus has occasionally been reported in association with Fuchs dystrophy but is uncommon.

Diagnosis

History

Patients commonly report gradually progressive blurred vision and glare.

A particularly characteristic symptom is that vision is worse after awakening and improves during the day. During sleep, the closed eyelids reduce evaporation from the corneal surface, allowing corneal edema to increase. After awakening, evaporation gradually helps reduce the edema.

Patients with more advanced disease may describe pain, foreign-body sensation, photophobia, and tearing, especially when epithelial bullae rupture.

A history of previous cataract surgery, other intraocular surgery, glaucoma, or uveitis is important because these conditions can accelerate endothelial failure.

Physical Examination

A complete ophthalmic examination should include visual acuity, intraocular pressure, slit-lamp examination, and dilated fundus examination when the posterior segment can be visualized.

Early Disease

In early disease, slit-lamp examination shows central corneal guttae.

These may be best appreciated using direct illumination, specular reflection, or retroillumination.

The guttae commonly begin centrally and gradually spread toward the peripheral cornea.

Moderate Disease

As disease progresses, the posterior corneal surface develops a characteristic beaten-metal or hammered-metal appearance because of numerous confluent guttae and associated endothelial pigmentation.

Descemet membrane becomes thickened.

Stromal edema develops, initially in the posterior cornea. Descemet folds may become visible as edema worsens.

Advanced Disease

Progressive edema eventually reaches the epithelium, producing microcystic epithelial edema.

The epithelial microcysts may merge into larger bullae. Rupture of these bullae produces significant pain and recurrent epithelial defects.

End-stage disease may show subepithelial fibrosis, anterior stromal scarring, superficial vascularization, and chronic bullous keratopathy.

Diagnostic Testing

Pachymetry

Corneal pachymetry measures central corneal thickness.

An increase in corneal thickness can indicate progressive edema and reduced endothelial function. Serial measurements can help assess progression.

However, corneal thickness should always be interpreted together with symptoms, slit-lamp findings, and endothelial imaging.

Specular Microscopy

Specular microscopy allows evaluation of endothelial cell density and morphology.

It can demonstrate reduced endothelial cell counts, guttae, polymegathism, and pleomorphism.

In advanced disease, dense guttae or severe corneal edema may make accurate endothelial cell counting difficult.

Confocal Microscopy

Confocal microscopy can provide additional information about endothelial morphology and may be useful when conventional visualization is limited.

B-Scan Ultrasonography

If severe corneal edema or coexisting cataract prevents adequate visualization of the posterior segment, B-scan ultrasonography can be used to exclude significant retinal or vitreous pathology.

Pathological Findings

Histopathology demonstrates a diffusely thickened Descemet membrane with characteristic excrescences or guttae.

There is a reduced number of endothelial cells, often with marked variation in cell size and shape.

Advanced disease may show subepithelial fibrosis, epithelial basement membrane abnormalities, bullous keratopathy, and superficial corneal neovascularization.

Differential Diagnosis

The differential diagnosis includes other causes of corneal endothelial failure or edema.

Important possibilities include pseudophakic or aphakic bullous keratopathy, posterior polymorphous corneal dystrophy, congenital hereditary endothelial dystrophy, iridocorneal endothelial syndrome, and chronic inflammatory or infectious endothelial disease.

Central herpetic disciform keratitis can cause corneal edema but is usually associated with inflammatory signs and a different clinical history.

Corneal pseudoguttae may occur transiently after trauma, intraocular inflammation, infection, or toxic injury and should be distinguished from true Fuchs dystrophy.

Treatment

Treatment depends on the severity of symptoms and degree of corneal decompensation.

First-Line Medical Treatment

For mild to moderate corneal edema, hypertonic sodium chloride 5% drops can be used during the day.

Hypertonic sodium chloride ointment is particularly useful at bedtime because it provides longer contact with the ocular surface.

These treatments draw water from the corneal epithelium and may temporarily improve vision and discomfort. They do not reverse the underlying endothelial disease or stop its progression.

Morning Edema

Because edema is often worse after sleep, some patients obtain temporary symptomatic benefit from increasing evaporation after awakening.

Historically, use of a hair dryer at arm’s length with cool or low-warm airflow directed toward the closed or blinking eyes has been suggested to encourage evaporation, although this is a symptomatic measure rather than disease-modifying therapy.

Management of Elevated Intraocular Pressure

If intraocular pressure is elevated, appropriate glaucoma therapy should be initiated because excessive pressure can further compromise endothelial function.

Choice of medication should take the overall ocular condition into account.

Management of Bullous Keratopathy

Painful epithelial bullae may be managed temporarily with lubrication and a therapeutic bandage contact lens.

Because an epithelial defect increases the risk of microbial keratitis, these patients require appropriate monitoring.

Recurrent or persistent painful bullae in an eye with poor visual potential may require additional palliative procedures, but in an eye with useful visual potential definitive endothelial replacement is usually preferred.

Surgical Treatment

Definitive treatment is indicated when corneal edema causes significant visual impairment or painful bullous keratopathy that is not adequately controlled medically.

Endothelial Keratoplasty

For most patients with Fuchs dystrophy who do not have significant anterior stromal scarring, endothelial keratoplasty is preferred.

DMEK

Descemet membrane endothelial keratoplasty (DMEK) replaces diseased Descemet membrane and endothelium with donor Descemet membrane and endothelial cells.

It generally provides rapid visual rehabilitation, minimal induced astigmatism, and excellent optical quality.

DSAEK/DSEK

Descemet stripping automated endothelial keratoplasty (DSAEK) or DSEK replaces the diseased endothelium and Descemet membrane along with a thin layer of donor posterior stroma.

It remains an effective option, although DMEK often provides faster visual recovery and better final optical quality when technically suitable.

Penetrating Keratoplasty

Penetrating keratoplasty (PKP) replaces the full thickness of the cornea.

It is generally reserved for patients with advanced Fuchs dystrophy who have substantial anterior stromal scarring, subepithelial fibrosis, or other corneal pathology that would limit vision even after endothelial replacement alone.

Compared with endothelial keratoplasty, PKP usually has a longer visual recovery period and greater risk of induced astigmatism and wound-related complications.

Fuchs Dystrophy and Cataract Surgery

Cataract and Fuchs dystrophy commonly coexist.

Before cataract surgery, the surgeon should assess the severity of endothelial disease using the clinical examination, pachymetry, endothelial imaging when possible, visual symptoms, and extent of guttae or edema.

Patients with relatively mild disease may undergo cataract surgery alone, but they should be counseled that postoperative corneal edema may be prolonged and that endothelial keratoplasty may eventually be required.

Patients with significant endothelial dysfunction and a visually important cataract may benefit from combined cataract surgery and endothelial keratoplasty, sometimes called a triple procedure.

Historical thresholds such as endothelial cell density below approximately 1,000 cells/mm² or markedly increased corneal thickness have been used to estimate risk, but contemporary surgical decisions are individualized and should not rely on a single numerical cutoff.

Follow-Up

Follow-up frequency depends on disease severity.

Patients with mild, stable disease may be examined approximately every 6–12 months, while those with progressive edema or declining vision require closer follow-up.

Monitoring should include visual acuity, slit-lamp examination, intraocular pressure, and assessment of corneal thickness or endothelial status when clinically useful.

Patients with epithelial defects or ruptured bullae need closer follow-up because of the risk of infectious keratitis.

Patient Education

Patients should understand that Fuchs dystrophy is usually a slowly progressive condition and that the rate of progression varies considerably between individuals.

Morning blur is characteristic because corneal edema increases while the eyelids are closed during sleep.

Hypertonic saline drops may sting, while ointment frequently causes temporary blur. These effects should be explained so that patients are not unnecessarily alarmed.

Patients considering cataract surgery should understand that their reduced endothelial reserve increases the risk of persistent postoperative corneal edema and eventual need for endothelial transplantation.

Prognosis

The natural course is progressive but variable.

Many patients remain mildly symptomatic for years, while others develop clinically significant corneal edema and visual impairment.

Modern endothelial keratoplasty has greatly improved prognosis. DMEK and DSAEK generally provide excellent corneal clarity and substantial visual improvement in appropriately selected patients.

Final vision depends not only on the cornea but also on other ocular conditions such as cataract, glaucoma, macular disease, and optic nerve disease.

Complications

Untreated advanced disease may lead to painful bullous keratopathy, recurrent epithelial erosions, infectious keratitis, corneal ulceration, fibrosis, scarring, and neovascularization.

Potential complications after corneal transplantation include graft rejection, graft failure, glaucoma, infection, astigmatism, wound problems, retinal detachment, uveitis, and endophthalmitis.

Following endothelial keratoplasty, additional procedure-specific complications can include graft detachment requiring rebubbling, primary graft failure, and endothelial cell loss.

Ophthalmology – Fracture, White-Eyed Blowout

Basics

Description

A white-eyed blowout fracture (WEBOF) is a trapdoor or greenstick fracture of the orbital floor or, less commonly, the medial orbital wall that causes entrapment of orbital soft tissue or an extraocular muscle. The entrapped muscle may become ischemic, producing severe restriction of ocular movement and persistent diplopia.

The condition occurs predominantly in children and adolescents, although young adults in their early 20s may also be affected.

The term white-eyed refers to the striking absence of external signs despite a potentially serious orbital injury. There may be little or no eyelid swelling, ecchymosis, or subconjunctival hemorrhage. Consequently, the injury may initially be mistaken for a concussion or minor facial trauma.

White-eyed blowout fracture is also known as a trapdoor orbital fracture.

Epidemiology

White-eyed blowout fractures occur primarily in children and young adults. There is no established racial predilection.

No definite sex predilection has been demonstrated, although males experience traumatic injuries more frequently overall.

The orbital floor is affected more commonly than the medial orbital wall or lamina papyracea.

The exact incidence and prevalence are unknown.

Risk Factors

The major risk factors are young age and recent blunt periocular trauma.

Common mechanisms include sports-related injuries, motor vehicle accidents, falls, and physical altercations.

Prevention

Prevention centers on reducing the risk of orbital trauma.

Children participating in sports should use appropriate polycarbonate protective glasses, goggles, face shields, or other sport-specific eye protection.

Age-appropriate seat belts, car seats, and other restraint systems should be used consistently in motor vehicles.

Pathophysiology

Two principal mechanisms have been proposed for orbital blowout fractures.

In the hydraulic mechanism, a blunt object strikes the globe and orbital entrance, suddenly increasing intraorbital pressure. This pressure is transmitted to the thin orbital floor or medial wall, causing the bone to fracture into an adjacent paranasal sinus.

In the buckling mechanism, a blow to the inferior orbital rim transmits force posteriorly through the orbital skeleton, causing the orbital floor to buckle and fracture.

The Pediatric Trapdoor Mechanism

The orbital bones of children are relatively thin, elastic, and incompletely calcified compared with those of adults.

Following blunt trauma, the orbital floor or medial wall may temporarily bend or crack open. Increased orbital pressure forces orbital fat, connective tissue, and sometimes an extraocular muscle through the opening.

Because pediatric bone is highly elastic, the fractured segment may immediately spring back toward its original position. This creates a trapdoor effect, tightly incarcerating the prolapsed orbital tissue.

The inferior rectus or its surrounding tissues are most commonly involved in orbital floor fractures. The medial rectus or adjacent tissues may be involved with medial wall fractures.

Prolonged incarceration can impair blood flow to the muscle and lead to ischemia, fibrosis, and permanent restrictive strabismus.

Oculocardiac Reflex

One of the most important features of a white-eyed blowout fracture is the oculocardiac reflex.

Traction on or entrapment of an extraocular muscle stimulates trigeminal afferent pathways and produces a vagal response.

Affected patients may develop nausea, vomiting, dizziness, bradycardia, hypotension, syncope, or, rarely, cardiac conduction abnormalities.

The nausea and vomiting can be dramatic and may be mistaken for manifestations of a concussion.

The combination of recent orbital trauma, restricted ocular motility, pain with eye movement, nausea, vomiting, or bradycardia should therefore raise immediate concern for a trapdoor fracture with tissue entrapment.

Etiology

The condition results from blunt periocular trauma.

Sports injuries are particularly common in children, but motor vehicle accidents, falls, and interpersonal trauma can also produce the injury.

Commonly Associated Conditions

Associated ocular injuries may include hyphema, vitreous hemorrhage, choroidal rupture, retinal injury, and other intraocular trauma.

The oculocardiac reflex may produce clinically important bradycardia and, rarely, heart block.

Significant intracranial injury is not a defining feature of white-eyed blowout fracture. Nevertheless, the mechanism of trauma should determine whether concurrent neurologic injury requires investigation.

Diagnosis

History

A typical patient has sustained recent blunt trauma to the periocular region.

The patient may complain of diplopia and significant pain when attempting to move the affected eye.

Nausea and vomiting, particularly when precipitated or worsened by attempted eye movement, are important diagnostic clues.

The absence of dramatic bruising or swelling should not reassure the clinician.

Loss of consciousness is not characteristic of an isolated white-eyed blowout fracture, although associated head injury must still be considered according to the mechanism and clinical findings.

Physical Examination

External Examination

The external appearance may be surprisingly normal.

There may be only minimal eyelid edema, minimal ecchymosis, or a small subconjunctival hemorrhage despite significant tissue entrapment.

This discrepancy between a relatively quiet external appearance and severe functional impairment is the hallmark of the condition.

Ocular Motility

Marked restriction of ocular movement is a major finding.

With an orbital floor trapdoor fracture, vertical motility is usually impaired, particularly upgaze, although the exact pattern depends on which tissues are incarcerated.

With a medial wall trapdoor fracture, horizontal motility may be restricted.

The child may refuse to open or move the eye because attempted movement produces significant pain, nausea, or vomiting.

Diplopia

Diplopia results from mechanical restriction of the entrapped muscle or surrounding connective tissues.

The severity of diplopia does not necessarily correlate with the amount of external swelling.

Facial Sensation

Contusion or injury of the infraorbital nerve may produce numbness or altered sensation over the cheek, upper lip, or lateral nose when the orbital floor is involved.

Complete Ophthalmic Examination

A complete examination is essential to exclude associated globe, retinal, and optic nerve injuries.

Visual acuity, pupillary responses, ocular motility, anterior segment findings, intraocular pressure when appropriate, and the posterior segment should be assessed.

Diagnostic Tests and Interpretation

CT Imaging

Thin-section CT of the orbits with multiplanar reconstruction is the preferred imaging study.

Both bone and soft-tissue windows should be reviewed carefully.

White-eyed blowout fractures can be subtle and easily missed on CT because the elastic fractured bone may return nearly to its normal position after trapping the orbital tissues.

Consequently, a CT report describing little or no displacement does not exclude clinically important entrapment when the history and examination are strongly suggestive.

Dedicated orbital imaging is preferable because a routine head CT may not provide sufficiently detailed evaluation of the orbital walls and extraocular muscles.

In children, radiation exposure should be minimized using appropriate pediatric CT protocols.

MRI and Plain Radiographs

Plain radiographs provide inadequate detail and are generally not useful when modern CT imaging is available.

MRI is not the initial study of choice for acute orbital fractures because CT provides superior assessment of the bony orbital anatomy.

Intracranial Imaging

Additional evaluation for intracranial trauma should be performed when indicated by the mechanism of injury, neurologic examination, or other concerning symptoms.

Other Diagnostic Considerations

If the patient has significant persistent bradycardia or another manifestation of the oculocardiac reflex, cardiac monitoring may be necessary.

In severe cases, hospital admission may be appropriate while definitive treatment is arranged.

Pathologically, the fracture may trap the extraocular muscle itself or only the perimuscular fascia, connective tissue, and orbital fat. Either situation can produce substantial restriction of ocular movement.

Differential Diagnosis

Concussion or Intracranial Injury

Nausea and vomiting following trauma can lead to an incorrect diagnosis of concussion.

The presence of marked ocular motility restriction and symptoms provoked by eye movement should raise suspicion for a trapdoor fracture and oculocardiac reflex.

Extraocular Muscle Contusion

Orbital trauma without entrapment can cause muscle edema and contusion, resulting in temporary diplopia and motility limitation.

However, simple contusion generally does not produce the pronounced oculocardiac symptoms associated with significant trapdoor entrapment.

Treatment

White-eyed blowout fracture with clinically significant entrapment is considered an urgent surgical condition.

Medical therapy alone cannot release incarcerated tissue.

The objective is to free the entrapped tissue before prolonged ischemia and fibrosis result in permanent restrictive strabismus.

Timing of Surgery

Patients with convincing clinical evidence of extraocular muscle or soft-tissue entrapment should receive urgent orbital surgical evaluation and prompt repair.

Surgery should not be unnecessarily delayed solely to allow orbital swelling to resolve, as might be appropriate for some uncomplicated adult blowout fractures.

Marked motility restriction associated with pain, nausea, vomiting, bradycardia, or other manifestations of the oculocardiac reflex strengthens the indication for urgent intervention.

Earlier literature commonly advocated repair within approximately 24–72 hours. In practice, the urgency is determined by the severity of entrapment and systemic manifestations, with significant oculocardiac reflex or severe restriction generally warranting particularly rapid intervention.

Preoperative Management

The patient should remain NPO when urgent surgery is anticipated.

Severe vomiting may result in dehydration, particularly when symptoms have persisted for many hours or days. Intravenous fluid replacement may therefore be necessary.

Antiemetics can be administered for symptomatic relief, although they may not fully control symptoms while the tissue remains entrapped.

The patient should undergo a complete ophthalmic examination and appropriate orbital imaging before surgery whenever the clinical situation permits.

Cardiac monitoring should be considered when significant bradycardia or conduction abnormalities are present.

Antibiotics and Corticosteroids

Some clinicians prescribe short courses of systemic antibiotics after orbital fracture repair, particularly when there is concern about sinus contamination. However, routine prophylactic antibiotics in otherwise uncomplicated closed fractures have limited supporting evidence.

Systemic corticosteroids have also historically been prescribed in an attempt to reduce post-traumatic edema and fibrosis. Their routine benefit in white-eyed blowout fractures has not been firmly established.

Neither antibiotics nor corticosteroids should delay definitive release of entrapped tissue.

Surgery and Other Procedures

Surgical treatment consists of orbital exploration and release of the incarcerated muscle, fascia, fat, and other soft tissues.

After the tissue is released, the surgeon assesses the residual orbital wall defect.

If the trapdoor bone returns to an appropriate position and there is no risk of recurrent entrapment, an implant may not always be necessary.

More commonly, a residual defect remains after tissue release. An orbital implant may then be positioned across the defect to prevent recurrent herniation or re-entrapment.

Both absorbable and nonabsorbable materials may be used according to the clinical situation and surgeon preference.

Many orbital floor trapdoor fractures can be repaired through a transconjunctival approach, avoiding an external skin incision.

Inpatient Considerations

Admission

Hospital admission may be required for intractable nausea and vomiting, dehydration, clinically important bradycardia, cardiac conduction abnormalities, or other associated injuries.

Postoperative Monitoring

Following successful release of entrapped tissue, nausea and vomiting caused by the oculocardiac reflex usually improve rapidly.

Visual acuity, pupils, pain, and orbital swelling should be monitored after surgery because postoperative orbital hemorrhage can rarely cause orbital compartment syndrome and compressive optic neuropathy.

Unexpected severe pain, rapidly increasing proptosis or swelling, reduced vision, or a new pupillary abnormality requires immediate assessment.

Cold compresses can be used during the early postoperative period to reduce edema and discomfort.

Postoperative Diplopia

Persistent diplopia immediately after successful surgery is common and does not necessarily indicate surgical failure.

The entrapped muscle may have sustained edema, ischemia, contusion, or neuropraxia. Ocular motility can therefore take weeks to months to recover.

Patients and their families should be counseled about this possibility before surgery.

In contrast, persistent or recurrent nausea, vomiting, severe movement-related pain, or other oculocardiac symptoms after repair may raise concern for inadequate release or recurrent entrapment and should prompt reassessment.

Ongoing Care and Follow-Up

Patients are usually reviewed within approximately one week after repair, with subsequent follow-up based on ocular motility and recovery.

Cold compresses are generally continued during the first few postoperative days.

Patients should avoid nose blowing, strenuous exercise, heavy lifting, and contact sports during the initial healing period as directed by the treating surgeon.

Visual function should be monitored carefully, and patients and families should be educated about symptoms of postoperative orbital hemorrhage.

A repeat dilated retinal examination may be appropriate after the acute injury period to identify delayed manifestations of associated ocular trauma.

Management of Persistent Diplopia

Temporary occlusion of one eye may be used for troublesome postoperative diplopia.

Care must be taken in young children because prolonged monocular occlusion can cause or worsen amblyopia.

Persistent ocular misalignment should be followed with serial measurements while the injured muscle recovers.

Definitive strabismus surgery should generally be deferred until ocular alignment and motility have stabilized, often for several months, because substantial spontaneous improvement may occur following timely fracture repair.

Patient Monitoring

The most important parameters during follow-up are visual acuity, pupillary function, ocular alignment, extraocular motility, diplopia, globe position, and recovery of facial sensation.

Persistent motility restriction does not necessarily indicate a poor outcome early after surgery. Improvement may continue gradually over weeks or months.

Prognosis

The prognosis is generally excellent when significant entrapment is recognized and released promptly.

Most appropriately treated patients experience substantial recovery of extraocular motility and resolution of diplopia in functionally important positions of gaze.

Some residual diplopia may remain in extreme gaze, particularly upgaze, without causing significant functional disability.

Delayed recognition and prolonged incarceration increase the risk of muscle ischemia, fibrosis, restrictive strabismus, and persistent diplopia.

Complications

One of the most important complications is delayed or missed diagnosis, particularly when the injury is mistaken for concussion or when a subtle fracture is overlooked on imaging.

Persistent diplopia and restrictive strabismus may occur because of ischemic or fibrotic damage to the entrapped muscle.

Surgical complications include orbital hemorrhage, compressive optic neuropathy, persistent infraorbital sensory disturbance, eyelid malposition, scarring, implant migration or extrusion, sinusitis, and orbital cellulitis.

Enophthalmos and hypoglobus are possible but are generally less prominent than in large adult blowout fractures because pediatric trapdoor fractures often involve relatively small bony defects.

The key clinical principle is that a child with minimal external trauma but severe ocular motility restriction, pain with eye movement, nausea, vomiting, or bradycardia should be presumed to have significant orbital entrapment until appropriately evaluated.

Ophthalmology – Fractures, Orbital Medial Wall

Basics

Description

An orbital medial wall fracture is a traumatic defect involving the bony medial wall of the orbit. The medial wall is formed mainly by the ethmoid bone, with contributions from the lacrimal, maxillary, and sphenoid bones.

Medial wall fractures may occur as extensions of other facial fractures or together with an orbital floor fracture. An isolated indirect or blowout fracture of the medial wall can also occur without disruption of the orbital rim.

Because the medial orbital wall is very thin, trauma may permit orbital fat and occasionally the medial rectus muscle or adjacent soft tissues to herniate into the ethmoid sinuses. This can lead to diplopia, ocular motility restriction, enophthalmos, or globe dystopia.

Epidemiology

The incidence and prevalence of medial orbital wall fractures vary according to the population and mechanism of injury. They are frequently seen in association with broader orbital or midfacial trauma.

Risk Factors

Orbital fractures occur more commonly in males and younger individuals, particularly those between approximately 15 and 30 years of age.

Important risk factors include participation in contact or projectile sports and activities associated with facial trauma. Substance use may indirectly increase risk through falls, interpersonal violence, and motor vehicle accidents.

Prevention

Protective eyewear should be used during sports and occupational activities involving high-velocity objects.

Sports such as baseball, softball, and hockey are important examples in which appropriate eye and facial protection can reduce the risk of orbital trauma.

Pathophysiology

Medial wall blowout fractures frequently occur together with orbital floor blowout fractures, although isolated medial wall fractures can also occur.

Blunt trauma to the orbital entrance can cause a sudden increase in intraorbital pressure. Because the medial wall is extremely thin, especially at the lamina papyracea, it may fracture under this pressure.

Orbital fat may then herniate into the ethmoid sinus. In more severe cases, the medial rectus muscle or surrounding connective tissue can become trapped within the fracture.

Entrapment may produce restricted horizontal ocular movement and diplopia. Large defects can also increase orbital volume and later result in enophthalmos or abnormal globe position.

Etiology

The main cause is blunt orbital or facial trauma.

A classic mechanism involves the orbital entrance being struck by an object larger than the diameter of the orbital opening, such as a fist, ball, dashboard, or other blunt object.

Commonly Associated Conditions

Medial orbital wall fractures may coexist with significant ocular injuries, including globe rupture, hyphema or microhyphema, traumatic iritis, commotio retinae, choroidal rupture, and traumatic optic neuropathy.

Because these associated conditions can threaten vision independently of the fracture itself, a complete ocular examination is essential.

Diagnosis

History

A careful history should establish the timing, mechanism, direction, and severity of the trauma.

Patients should be asked about decreased vision, diplopia, ocular pain, facial numbness, and changes in globe position.

A history of nausea, vomiting, or bradycardia, especially when triggered by eye movement, raises concern for extraocular muscle or soft-tissue entrapment causing an oculocardiac reflex.

This is particularly important in children and in patients with an associated orbital floor fracture.

Physical Examination

Periorbital Findings

Patients may develop eyelid edema and ecchymosis following the injury.

Because the medial orbital wall communicates with the ethmoid sinuses, air may enter the orbital and eyelid tissues, producing orbital or eyelid emphysema. Subcutaneous crepitus may sometimes be detected on examination.

Visual Assessment

Visual acuity should be documented in both eyes whenever possible.

Pupillary examination is essential because a relative afferent pupillary defect may indicate significant retinal or optic nerve injury.

A complete anterior and posterior segment examination should be performed to identify associated traumatic ocular pathology.

Diplopia and Ocular Motility

Patients may develop diplopia due to orbital edema, hemorrhage, muscle contusion, or mechanical entrapment.

Entrapment of the medial rectus muscle or adjacent tissues can produce horizontal motility restriction.

Ocular movements should therefore be carefully assessed in all directions of gaze.

Globe Dystopia

Large medial wall fractures may allow orbital contents to herniate into the ethmoid sinus.

This increases effective orbital volume and can lead to enophthalmos or other globe displacement. Enophthalmos may initially be masked by acute swelling and become more apparent after edema resolves.

Forced-Duction Testing

Forced-duction testing can be useful when it is necessary to distinguish mechanical restriction from a neurogenic ocular motility disorder.

Resistance to passive movement supports a restrictive process, whereas normal passive movement is more consistent with a paralytic cause.

This test is not necessary in every patient and should be performed only when clinically appropriate.

Diagnostic Tests and Interpretation

Imaging

CT of the orbits with thin sections and multiplanar reconstruction is the principal imaging study for suspected medial orbital wall fractures.

CT can demonstrate the bony defect, associated orbital floor fractures, herniation of orbital fat into the ethmoid sinus, and displacement or possible entrapment of extraocular muscles and adjacent soft tissues.

Imaging findings should always be correlated with the clinical examination because herniation seen on CT does not necessarily mean that clinically significant entrapment is present.

Differential Diagnosis

Orbital hemorrhage or edema without fracture can produce swelling, diplopia, and motility limitation, but CT demonstrates no corresponding bony defect.

A cranial nerve palsy can also produce ocular misalignment and diplopia. Unlike mechanical entrapment, forced-duction testing is generally normal.

Other possibilities include extraocular muscle contusion, orbital hematoma, traumatic neuropathy, and associated orbital floor fractures.

Treatment

Management depends on the size of the fracture, presence of soft-tissue or muscle entrapment, diplopia, ocular motility, globe position, associated ocular injuries, and the age of the patient.

Many uncomplicated medial wall fractures can be managed conservatively.

Initial Management

The immediate priority is to identify and treat any associated vision-threatening ocular or orbital injury.

Cold compresses can be used during the early period after trauma to reduce swelling.

Patients should be instructed to avoid nose blowing, because increased sinus pressure can force additional air or contaminated sinus contents into the orbit.

Nasal decongestants may be considered in selected patients when not contraindicated.

Antibiotics

Older protocols often recommended prophylactic broad-spectrum oral antibiotics because the fracture communicates with the paranasal sinuses.

In current practice, routine prophylactic antibiotics for every uncomplicated closed orbital fracture are not universally required.

Antibiotics may be appropriate when there are additional risk factors such as active sinusitis, contaminated wounds, open fractures, immunocompromise, or other significant infectious risks.

Corticosteroids

A short course of systemic corticosteroids may occasionally be considered when there is substantial orbital edema.

Their main purpose is to reduce swelling and facilitate assessment of ocular motility. They are not routinely required for every fracture.

Referral

Patients with orbital trauma should receive appropriate ophthalmologic assessment to exclude associated ocular injuries.

Patients with significant diplopia, persistent motility restriction, enophthalmos, a large fracture, or suspected tissue entrapment should be referred to an oculoplastic or orbital surgeon or another surgeon experienced in orbital fracture management.

Urgent Referral

Patients with nausea, vomiting, or bradycardia associated with restricted ocular movement require urgent specialist evaluation because these findings may indicate extraocular muscle entrapment with an oculocardiac reflex.

Such patients may require urgent surgical release.

Pediatric Considerations

Children may develop a characteristic trapdoor fracture.

Because pediatric orbital bones are relatively elastic, a fractured segment can temporarily displace and then recoil toward its original position, trapping orbital soft tissue or an extraocular muscle.

This can produce a white-eyed blowout fracture, in which severe motility restriction and systemic symptoms occur despite minimal external bruising.

A child with orbital trauma and diplopia, marked motility restriction, nausea, vomiting, or bradycardia should be considered to have possible entrapment even if the external examination appears relatively normal.

When entrapment is confirmed or strongly suspected, early surgical release is generally indicated.

Surgery and Other Procedures

Not all medial wall fractures require surgery.

Surgical repair may be considered when there is persistent functionally significant diplopia with mechanical restriction, clinically important enophthalmos or globe dystopia, significant soft-tissue entrapment, or a large defect likely to cause late orbital volume expansion.

A medial wall fracture that is continuous with a large orbital floor fracture may be more likely to require reconstruction.

Historically, enophthalmos greater than approximately 2 mm has been used as one factor supporting surgical repair when cosmetically or functionally significant.

For nonurgent fractures requiring reconstruction, surgery is commonly performed after acute swelling improves, often within approximately 1–2 weeks, although timing should be individualized.

Entrapment associated with an oculocardiac reflex, particularly in children, may require much earlier surgery.

Surgical Approaches

An orbital floor approach through an eyelid or transconjunctival incision can be extended superiorly to expose the medial wall when both areas require repair.

An isolated medial wall fracture can also be approached through a transcaruncular incision, which provides direct access to the medial orbit without an external skin incision.

During surgery, entrapped tissue is released and the defect may be reconstructed with an orbital implant when necessary to restore orbital volume and prevent recurrent herniation.

Ongoing Care and Follow-Up

Follow-up should assess visual acuity, pupillary responses, ocular motility, diplopia, globe position, and resolution of swelling and orbital emphysema.

Patients may require continued care from an ophthalmologist, with involvement of oculoplastic surgery, otolaryngology, or oral and maxillofacial surgery depending on the associated injuries.

Persistent or worsening diplopia, progressive enophthalmos, new visual loss, increasing pain, fever, proptosis, or worsening motility restriction requires reassessment.

Patient Education

Patients should avoid nose blowing and activities that markedly increase sinonasal pressure during the early healing period.

They should seek urgent medical attention for new or worsening vision loss, severe ocular pain, increasing redness or swelling, fever, worsening diplopia, or nausea and vomiting associated with eye movement.

Prognosis

The prognosis depends primarily on the severity of the initial trauma and associated ocular, orbital, and facial injuries.

Many uncomplicated medial wall fractures heal well with conservative management.

Patients with significant extraocular muscle entrapment, extensive tissue herniation, traumatic optic neuropathy, or major associated globe injury have a more guarded prognosis.

Complications

Potential complications include decreased vision, persistent diplopia, restrictive strabismus, enophthalmos, and abnormal globe position.

Entrapped extraocular muscle or soft tissue can result in persistent motility dysfunction if not recognized and managed appropriately.

Because the medial wall communicates with the ethmoid sinuses, infection can occasionally spread into the orbit and produce orbital cellulitis.

The most serious visual complications generally result from associated injuries such as globe rupture, retinal damage, or traumatic optic neuropathy, rather than from the medial wall fracture itself.

Ophthalmology – Orbital Floor Fractures

Basics

Description

An orbital floor fracture is a traumatic disruption of the bony floor of the orbit. The fracture may occur as an extension of an inferior orbital rim fracture, or it may occur as an isolated blowout fracture.

An indirect or blowout fracture occurs when the orbital floor fractures while the orbital rim remains intact. Orbital soft tissues, including orbital fat and occasionally an extraocular muscle, may herniate or become entrapped within the fracture defect. This can produce diplopia, restricted ocular motility, enophthalmos, and infraorbital sensory loss.

Epidemiology

The incidence and prevalence of orbital floor fractures vary according to population and mechanism of injury. They are particularly common following facial trauma in adolescents and young adults.

Risk Factors

Orbital floor fractures occur more commonly in males and younger individuals, particularly those between approximately 15 and 30 years of age.

Participation in contact or projectile sports increases the risk. Substance use may also increase risk through its association with interpersonal violence, falls, and motor vehicle trauma.

Prevention

Appropriate protective eyewear should be worn during sports and occupations involving high-velocity objects.

Sports such as baseball, softball, and hockey are important examples in which properly fitted protective equipment can reduce the risk of orbital and ocular trauma.

Pathophysiology

Two principal mechanisms have traditionally been proposed to explain orbital floor blowout fractures.

The hydraulic theory proposes that a relatively large, nonpenetrating object strikes the orbital entrance and rapidly increases intraorbital pressure. The globe and orbital contents are displaced posteriorly, transmitting pressure to the orbital walls. The weakest portion of the orbit then fractures, commonly involving the thin posterior-medial orbital floor overlying the maxillary sinus.

The buckling theory proposes that an impact to the inferior orbital rim transmits a compressive force posteriorly through the orbital bones. This causes the relatively thin orbital floor to buckle and fracture even when the orbital rim itself remains intact.

Following either mechanism, orbital fat and other soft tissues may prolapse into the maxillary sinus. In some patients, the inferior rectus muscle or surrounding connective tissue becomes entrapped, producing restrictive ocular motility.

Etiology

Orbital floor fractures are caused by blunt facial or orbital trauma.

A classic mechanism involves an object larger than the orbital opening, such as a fist, ball, dashboard, or other blunt object, striking the orbital region.

Associated Ocular Injuries

Because considerable force may be required to produce an orbital fracture, a complete evaluation for associated ocular trauma is essential.

Potential associated injuries include globe rupture, hyphema or microhyphema, traumatic iritis, commotio retinae, choroidal rupture, and traumatic optic neuropathy.

These injuries may be more immediately vision-threatening than the orbital fracture itself.

Diagnosis

History

The clinician should determine the exact mechanism, timing, and severity of trauma.

Patients should be questioned about diplopia, decreased vision, ocular pain, facial numbness, and changes in the position of the eye.

A classic history involves blunt trauma from an object larger than the orbital opening.

Particular attention should be given to nausea, vomiting, dizziness, or bradycardia after orbital trauma. These findings can indicate an oculocardiac reflex caused by extraocular muscle or soft-tissue entrapment and may require urgent surgical assessment.

Physical Examination

Examination commonly demonstrates periorbital edema and ecchymosis.

Visual acuity, pupils, intraocular structures, and the posterior segment should be examined carefully to exclude associated ocular injury.

Ocular Motility and Diplopia

Diplopia may occur because of edema, hemorrhage, muscle contusion, nerve injury, or mechanical entrapment.

Patients with orbital floor fractures commonly have limitation of upgaze, downgaze, or both, depending on the tissues involved.

Persistent restriction, particularly when accompanied by nausea, vomiting, or bradycardia, raises concern for entrapment.

Globe Position

Enophthalmos may occur when orbital contents herniate through a sufficiently large floor defect, effectively increasing orbital volume.

The globe may also become displaced inferiorly, producing hypoglobus.

Significant enophthalmos may initially be concealed by acute orbital edema and become more apparent after the swelling subsides.

Infraorbital Sensation

Damage or compression of the infraorbital nerve may cause hypesthesia or paresthesia of the lower eyelid, cheek, lateral nose, and upper lip on the affected side.

Orbital Emphysema

Air may enter the orbit from the adjacent maxillary sinus, producing orbital or eyelid emphysema.

For this reason, patients should be instructed not to blow their nose following an orbital fracture.

Orbital Rim

Palpation may reveal tenderness or a step-off deformity when the fracture extends to involve the orbital rim.

Forced-Duction Testing

Forced-duction testing can help distinguish mechanical restriction from a neurogenic motility deficit.

After appropriate topical anesthesia, the globe is gently manipulated to determine whether passive movement is mechanically restricted.

A positive forced-duction test supports restrictive entrapment. However, the need for this test depends on the clinical situation, and imaging plus specialist examination frequently provides the necessary information.

Diagnostic Testing

Imaging

CT of the orbits with thin sections and multiplanar reconstruction is the principal imaging study for suspected orbital floor fracture.

CT can demonstrate the location and extent of the bony defect, herniation of orbital fat into the maxillary sinus, associated orbital wall fractures, and displacement or possible entrapment of extraocular muscles and adjacent soft tissues.

Importantly, radiographic herniation of tissue does not by itself establish clinically significant entrapment. The CT findings must be interpreted together with ocular motility, symptoms, and the remainder of the clinical examination.

Differential Diagnosis

Orbital hemorrhage and edema without fracture may produce swelling, proptosis, diplopia, and restricted movement, but CT does not demonstrate a bony fracture.

A cranial nerve palsy may also cause diplopia and ocular motility abnormalities. Unlike a mechanically restrictive fracture, passive globe movement is generally not restricted.

Muscle contusion, traumatic neuropathy, orbital hematoma, and other orbital injuries should also be considered.

Treatment

Treatment depends on the size of the fracture, presence of tissue entrapment, ocular motility, diplopia, globe position, associated injuries, and the patient’s age.

Not every orbital floor fracture requires surgery.

Initial Management

The first priority is identification and management of potentially vision-threatening injuries, particularly open-globe injury, orbital compartment syndrome, retinal injury, and traumatic optic neuropathy.

Cold compresses can be used during the early post-traumatic period to reduce swelling.

Patients should be specifically instructed to avoid nose blowing, because increased intranasal pressure may force air or contaminated sinus material through the fracture into the orbit.

Nasal decongestants may be considered in selected patients when not otherwise contraindicated.

Analgesia should be provided as necessary.

Antibiotics

Older treatment protocols frequently recommended prophylactic broad-spectrum oral antibiotics, particularly when an orbital fracture communicated with a paranasal sinus.

In contemporary practice, routine prophylactic antibiotics for every uncomplicated closed orbital floor fracture are not universally recommended, because evidence supporting their benefit is limited.

Antibiotic therapy may nevertheless be appropriate in selected patients, such as those with contaminated wounds, active sinus infection, open fractures, immunocompromise, or other increased infectious risk. Management should therefore be individualized.

Corticosteroids

A short course of systemic corticosteroids may occasionally be considered when substantial orbital edema makes assessment of ocular motility difficult.

They are not mandatory for every orbital floor fracture, and contraindications to systemic corticosteroid therapy must be considered.

Referral

Patients with an orbital floor fracture should receive appropriate ophthalmic assessment to exclude associated ocular injuries.

Patients with persistent diplopia, significant motility restriction, enophthalmos, large fractures, or suspected entrapment should be evaluated by an oculoplastic/orbital surgeon or other surgeon experienced in orbital fracture management.

Routine nonurgent fractures can generally be reassessed after the initial edema begins to resolve.

Urgent Referral

Suspected extraocular muscle or soft-tissue entrapment requires urgent specialist assessment.

The combination of restricted eye movement with nausea, vomiting, or bradycardia is particularly concerning because it may represent the oculocardiac reflex.

This situation should not simply be observed for several days while awaiting resolution of swelling.

Pediatric Considerations

Children can sustain a characteristic trapdoor orbital floor fracture. Because pediatric bone is relatively elastic, the fractured bone may temporarily displace and then recoil toward its original position, trapping extraocular muscle or orbital soft tissue.

External bruising and swelling may be surprisingly mild, producing the so-called white-eyed blowout fracture.

A child with orbital trauma, marked motility restriction, diplopia, nausea, vomiting, or bradycardia should therefore be considered to have possible entrapment even when external signs appear minor.

Confirmed or strongly suspected pediatric entrapment generally requires urgent surgical evaluation and early release of the entrapped tissue.

Surgical Treatment

Many orbital floor fractures can be managed conservatively, particularly when diplopia is improving, ocular motility is recovering, and clinically significant enophthalmos is absent.

Surgery is considered when there is persistent functionally significant diplopia with restrictive motility, clinically important enophthalmos or hypoglobus, a sufficiently large defect likely to produce significant late globe displacement, or confirmed tissue entrapment.

Historically, involvement of approximately 50% or more of the orbital floor has been used as one factor suggesting an increased risk of late enophthalmos. However, fracture size alone should not determine management.

Similarly, enophthalmos greater than approximately 2 mm may support repair when it is clinically or cosmetically significant.

For fractures requiring nonurgent reconstruction, surgery is commonly performed after initial swelling has improved but before fibrosis becomes established, often within approximately 1–2 weeks. The timing should be individualized.

Entrapment associated with an oculocardiac reflex or a pediatric trapdoor fracture may require substantially earlier intervention.

Surgical Procedure

The goals of surgery are to release entrapped orbital tissue, restore orbital anatomy and volume, and support the orbital contents.

Entrapped tissues are carefully freed from the fracture site. An orbital implant or other reconstructive material may then be positioned over the bony defect to separate the orbital contents from the maxillary sinus and restore the contour of the orbital floor.

Follow-Up

Patients should be monitored for changes in visual acuity, pupils, ocular motility, diplopia, globe position, and infraorbital sensation.

Follow-up with ophthalmology is appropriate, with involvement of oculoplastic surgery, otolaryngology, or oral and maxillofacial surgery according to the fracture pattern and local treatment approach.

Persistent or worsening visual loss, increasing pain, proptosis, severe motility restriction, fever, or new neurologic symptoms requires prompt reassessment.

Patient Education

Patients should understand that the fracture itself is only one component of orbital trauma and that associated ocular injuries may determine the ultimate visual outcome.

They should avoid nose blowing and activities that markedly increase sinonasal pressure during the early healing period.

New or worsening vision loss, severe pain, increasing swelling, fever, worsening diplopia, nausea or vomiting associated with eye movement, or other significant changes should prompt urgent medical evaluation.

Prognosis

The prognosis is generally favorable in uncomplicated orbital floor fractures.

Final outcome depends largely on the severity of the initial trauma, associated ocular injuries, degree of soft-tissue damage, presence of entrapment, and development of late enophthalmos or persistent diplopia.

Early recognition of muscle entrapment is particularly important because prolonged ischemia and fibrosis can result in persistent motility dysfunction.

Complications

Important complications include persistent diplopia, restrictive strabismus, enophthalmos, hypoglobus, and persistent infraorbital nerve hypesthesia.

Visual loss may occur because of associated globe, retinal, or optic nerve injury rather than from the floor fracture itself.

Less commonly, infectious complications such as orbital cellulitis may develop, particularly when infection spreads from an adjacent paranasal sinus.